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Abstract
Changing Landscapes: Perspectives of Young African American Women of Population-Wide
Testing for Hereditary Breast Cancer Mutations
By Alesha Henderson, MA
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Director: Maghboeba Mosavel, Ph.D., M.A.
Associate Professor, Department of Health Behavior and Policy

Virginia Commonwealth University, 2020

INTRODUCTION: Young African American women continue to die from breast cancer at
higher rates than White women. In an effort to promote breast cancer prevention, populationwide testing (PWT) for all women in the U.S. starting at age 30 is a potential future initiative that
is garnering a lot of attention. The decreasing cost of genetic testing may make this a possible
reality in the future. However, African American women currently utilize genetic testing for
hereditary breast cancer at lower rates than White women. Therefore, if young African American
women are not prioritized in a future roll out of PWT, then existing breast cancer and genetic
testing disparities will likely continue to widen.
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PURPOSE: The purpose of this dissertation was to conduct a sequential exploratory mixed
methods study to understand young African American women’s (18-30 years) perspectives
towards hereditary breast cancer mutations, direct to consumer testing, PWT, as well as health
communication preferences. This study also aimed to explore the factors that influence intentions
to participate in such a service in the future.
METHODS: Seven focus groups were conducted with 39 young women residing in a southern
community and attending two local universities. A\thematic analysis was conducted using
MAXQDA qualitative software to identify themes and subthemes. A survey was developed
based upon focus group findings and tested using two rounds of cognitive interviews (n=10). The
survey was distributed via Qualtrics Online Sample (n=170) to examine the factors that influence
intentions to participate in PWT. Simple and multiple regressions were conducted to understand
which factors were significantly associated with intentions.
RESULTS: Focus group participants had limited to no knowledge about hereditary breast cancer
mutations. Participants indicated that it was important for PWT to be accessible to everyone,
normalized in American society, and to be thoroughly researched before it is presented as a
viable option to the general public. Motivators to participate in PWT included having a family
history of breast cancer, access to equitable healthcare quality, and concerns for future offspring. Barriers to intended participation in PWT included medical mistrust and concerns about
affordability. Moreover, survey findings indicated that participants had moderate knowledge of
hereditary breast cancer mutations and moderate levels of medical mistrust. Separate unadjusted
10

and adjusted multiple regressions indicated that both subjective norms and motivators to
participate in direct to consumer testing remained significant predictors of intentions to
participate in PWT after accounting for sociodemographic variables.
CONCLUSION: This was the first study to preemptively explore young African American
women’s perspectives and intentions to participate in future PWT. As discussions continue
about the potential for this new service, it will be imperative for researchers and public health
practitioners to prioritize the needs and preferences of young African American women when
designing interventions and potential health promotion strategies. This study findings provide
potential avenues for future research, public health programming, trainings, and public
campaigns in this area.
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Chapter 1: Introduction
Background

African American women are more likely to die from breast cancer than any other racial
group (Desantis et al. 2019). Despite White women having the highest incidence of breast
cancer, African American women are most likely to be diagnosed at earlier ages, later stages, and
more likely to be diagnosed with triple negative breast cancer that lacks proper treatment and is
associated with the presence of a hereditary breast cancer mutation. This disparity worsens when
examining young African American women (>40 years). Young African American women, who
are younger than the recommended mammography screening age, not only have the highest
incidence and mortality rates of breast cancer but are also most likely to be diagnosed with triple
negative breast cancer. Studies have also consistently found a high rate of hereditary breast
cancer mutations amongst young African American women breast cancer survivors but that
African American women tend to utilize genetic counseling and testing for hereditary breast
cancer mutations at lower rates than White women (Armstrong, Micco, Carney, Stopfer, & Putt,
2005; Jones et al., 2016; Pal et al., 2015). To promote breast cancer prevention amongst all
women in the United States, population-wide testing (PWT) for hereditary breast cancer
mutations is being proposed for all women starting at age 30. However, given the current low
participation rates of African American women in genetic counseling and testing for hereditary
breast cancer mutations, the benefits of such a proposed initiative may not reach this group and
in turn only widen existing breast cancer disparities. Understanding young African American
women’s perspectives and intentions to participate in PWT for hereditary breast cancer
12

mutations, may help to design interventions and health promotion programming to ultimately
increase participation in this potential new service.
Genetic Counseling and Testing and African American women
Genetic counseling and testing (GCT) for hereditary breast cancer mutations could
provide a unique pathway to prevention and treatment of breast cancer among African American
women (Force, 2019). Current statistics estimate that the breast cancer gene 1 and breast cancer
gene 2 (BRCA1/2) account for between 5-10 percent of all breast cancers (Force, 2019). Genetic
testing for BRCA1/2 was recently expanded to multi-gene panel testing to account for other
hereditary breast cancer genes, including PALB2, ATM, TP53, PTEN and a host of others
(Afghahi & Kurian, 2017). These additional genes are said to account for between 5 and 6
percent of all breast cancers (Afghahi & Kurian, 2017). Given that African American women
utilize genetic counseling and testing at lower rates than White women (Armstrong et al., 2005;
Jones et al., 2019; McCarthy et al., 2016), researchers know considerably less about the
prevalence of hereditary breast cancer mutations in this group. Malone et al. found that 4% of all
breast cancers amongst African Americans had a BRCA1/2 mutation present (Malone et al.,
2006). Pal et al. found that 20% of African American women with triple negative breast cancer
in the study sample had a BRCA1/2 mutation and that those diagnosed with triple negative breast
cancer at younger ages had an even higher percentage of BRCA1/2 mutations (Pal et al., 2015).
Further, they found that 22 percent of African American women under the age of 35 had a
BRCA1/2 mutation (Pal et al., 2015). When examining rates in multi-gene panel testing, Churpek
et al. (2015) found that among the 65 African American women in their sample with a hereditary
13

breast cancer mutation, the sample consisted of 57 different types of hereditary breast cancer
mutations (Churpek et al., 2015). Further, 20 percent of African American women with a
hereditary breast cancer mutation were carriers of non-BRCA 1/2 genes from the multi-gene
panel test (Churpek et al., 2015). These study findings point to the potential interconnectedness
of some African American women’s experiences with breast cancer and the presence of
hereditary breast cancer mutations as well as the need to ensure that this group also reaps the
benefits of PWT for hereditary breast cancer mutations.
The presence of hereditary breast cancer mutations in African American women is of
concern because mutation carriers have an elevated risk (40-80%) of developing breast cancer
over their lifetime (Institute, 2018 ; Petrucelli, Daly, & Feldman, 2010), compared to the
average risk of 12% (DeSantis, Ma, Goding, Newman, & Jemal, 2017; Institute, 2018 ; Petrucelli
et al., 2010). These mutations are hereditary in nature and are passed down from one family
member to another (Petrucelli et al., 2010). The risk of having a hereditary breast cancer
mutation among children and siblings of a mutation carrier is 50%, while nieces and nephews of
a mutation carrier have a hereditary breast cancer mutation risk of 25% (Petrucelli et al., 2010).
Getting tested not only has implications for understanding their own risks for breast cancer but
also that of their families. Current recommendations from the National Comprehensive Cancer
Network advise women who have a family history of breast cancer that is suggestive of a
hereditary breast cancer mutation to undergo genetic counseling and testing beginning at 18
years old (NCCN, 2018). Several prevention strategies are available to women who find out that
they are hereditary breast cancer mutation carriers, including preventive double mastectomy,
14

chemoprevention, and more frequent screening schedules than women who are not carriers
(Force, 2019).
Barriers and Motivators to Genetic Counseling and Testing for African American women
Most extant research has focused on the perspectives and knowledge levels around
hereditary breast cancer of African American women (<40) with a family or personal history of
breast cancer suggestive of a hereditary breast cancer mutation (Adams, Christopher, Williams,
& Sheppard, 2015; Hughes, Fasaye, Lasalle, & Finch, 2003; Kessler et al., 2005; Sheppard et al.,
2014; Sheppard, Mays, Tercyak, & LaVeist, 2013). Prior studies have indicated that lack of
knowledge, high cost of testing, medical mistrust, limited access to healthcare, perceived familial
approval of testing, and lack of physician recommendation are all barriers to the utilization of
genetic counseling and testing services (Adams et al., 2015; McCarthy et al., 2016; Sheppard et
al., 2014; Sheppard et al., 2013; Thompson et al., 2012). For example, Sheppard et al. 2014
found that African American women at high risk for hereditary breast cancer mutations were
worried about how their genetic data would be stored and used against them in the future,
potential high cost of testing, as well as issues surrounding access to healthcare services
(Sheppard et al., 2014). African American women at high risk for breast cancer listed motivators
to participate in genetic counseling and testing including, the potential benefit of disclosing their
status to family members so that they can also be aware of their future breast cancer risk, the
ability to have the counseling and testing covered by insurance, and the ability to help other
individuals in the Black community (Sheppard et al., 2014).
15

Studies focusing on the perspectives of African American women without a family or
personal history of breast cancer have been limited. Adams et al. (2015) employed intercept
interviews with African American women without a family history suggestive of hereditary
breast cancer at public places in Washington, D.C. to understand perspectives of hereditary
breast cancer mutations (Adams et al., 2015). Study participants mentioned similar advantages
and disadvantages of hereditary breast cancer mutations as African American women at high risk
for the mutations including, cancer prevention and the ability to inform family members of their
breast cancer risk, medical mistrust, and potential emotional distress caused by knowing their
status (Adams et al., 2015). However, many of the women indicated that they would participate
in testing if offered to them (Adams et al., 2015). Currently, there is only one study that includes
African American women’s perspectives about and perceived acceptability of PWT but the mean
age of participants was 37.7 years (Rubinsak et al., 2019). If PWT is implemented in the future,
it will be imperative to understand whether African American women approaching the proposed
screening age (18-30) for PWT mirror those of older African American women.
The Push for Population-wide testing
In 2014, the founder of hereditary breast cancer mutations, Mary-Claire King, and
colleagues called for PWT for BRCA1/2 mutations for all women regardless of their family
history of breast cancer beginning at age 30. The call for PWT was prompted by a study that
indicated that up to 50 percent of hereditary breast cancer mutations are missed with current
screening criteria (King, Levy-Lahad, & Lahad, 2014) . Furthermore, King et al. 2014 expressed
concerns about genetic counseling and testing not being used until after a woman has been
16

diagnosed with breast cancer instead of being used as a form of breast cancer prevention (King et
al., 2014). Furthermore, making the switch to PWT would eliminate the current model that
hinges on physicians as gatekeepers to genetic counseling and testing for the mutations. Prior
research has shown that physicians lack knowledge about genetic counseling and testing for
hereditary breast cancer mutations. Moreover, Bellcross et al. 2011 found that less than 20
percent of primary care physicians knew all of the increased-risk for hereditary breast cancer
mutations scenarios provided in the study (Bellcross et al., 2011). The elimination of the need for
physician recommendation for genetic counseling and testing could be beneficial to all women
but could be transformative for breast cancer prevention amongst African American women
given that formative research has consistently indicated that lack of physician recommendation is
a major barrier to participation in genetic counseling and testing.
As can be expected of any new preventive service, there are several oppositions to PWT.
Opponents, of PWT argue that it is hard to justify implementing PWT in more diverse and larger
populations, such as the United States, that may prove to not be cost effective based upon current
BRCA1/2 risk estimates (Foulkes, Knoppers, & Turnbull, 2016; Long & Ganz, 2015).
Furthermore, the research supporting PWT is largely based upon studies with Ashkenazi Jews,
who are known to have a high prevalence of hereditary breast cancer mutations (Foulkes et al.,
2016). Therefore, given that the United States has a more diverse population, there will also be
increased risk for false positives as well as the identification of variants of unknown significance
that cause unnecessary psychological distress, especially in minority populations (Foulkes et al.,
2016; Yurgelun, Hiller, & Garber, 2015). Despite the challenges to implementation of PWT,
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recent studies indicating the cost-effectiveness of PWT and the acceptability of this initiative to
women provide strong support for this initiative to become a reality in the future (Manchanda &
Gaba, 2018; Rubinsak et al., 2019). Given the potential challenges of implementing PWT as it
relates to minority populations, it is important to proactively understand the potential challenges
and barriers that may impact African American women’s uptake of PWT.
Potential Population-wide testing and Young African American women
African American women from the millennial generation are an important target
population for this study given that, if implemented, PWT would begin at 30 years for all women
in the United States. The perspectives of younger African American women, who are
approaching the proposed screening age for PWT, are important because they are approaching
eligibility to use this service as a pathway to breast cancer prevention if PWT was to be
implemented. African American women are disproportionately impacted by the breast cancer
disparity and currently utilize genetic counseling and testing for hereditary breast cancer
mutations at lower rates than White women, therefore it is imperative that researchers
preemptively gather the perspectives of young African American women towards PWT. Their
perspectives would provide insights into recommendations for public health practitioners at both
local and state health departments to reach and raise awareness in this group around PWT for
hereditary breast cancer mutations. Moreover, their participation in counseling and testing could
provide a better understanding of variants of unknown significance found in this population.
Some may argue that capturing this population’s perspectives would be premature since this is
still an ongoing debate but it is critical that we preemptively explore the perspectives and needs
18

of populations that are underrepresented in genetic counseling and testing services as well as
those that are disproportionately impacted by breast cancer when thinking about rolling out
PWT. If the tides do shift towards PWT for hereditary breast cancer mutations in the United
States, disparities in both breast cancer and genetic counseling and testing utilization among
younger African American women will continue if we do not proactively seek out their
perspectives of this potential shift.
Younger African American women’s perspectives towards genetic counseling and testing
for hereditary breast cancer mutations may be vastly different from older African American
women, given that they have been exposed to the proliferation of direct to consumer genetic
services that provide information about the connection between their genes and health to their
front door without the need for a physician recommendation (Bowen & Khoury, 2018; Estrada,
2017). The millennial generation of African American women born between 1982 and 2004
came of age during the technology revolution and most recently during the rise of direct to
consumer genetic testing used to provide answers about ancestry and health. Direct to consumer
genetic testing services (DTC testing), such as Ancestry.com and 23andMe, are steadily
increasing in popularity in the United States (Bowen & Khoury, 2018). To date, there have been
a limited number of studies that provide insight into DTC testing uptake and the perspectives of
racial minorities on DTC testing (Bloss et al., 2010; Carroll et al., 2019; Hensley Alford et al.,
2011; Landry et al., 2017). Studies have found that African Americans use DTC testing at similar
rates as Whites and are more interested in using these services to learn about ancestry than
disease information (Carroll et al., 2019; Landry et al., 2017). However, none have focused
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specifically on young African American women’s perspectives of DTC testing services. There
are distinct differences between DTC testing and population-wide testing in that DTC testing is
largely handled by private companies whereas PWT would be implemented by the healthcare
system. Despite these differences, young African American women’s perspectives on an already
widely available genetic counseling and testing service, such as DTC testing, could provide
further insight into their perspectives about PWT in the future.
Research Aims and Hypotheses
To date, few, if any studies have focused on the knowledge gaps and perspectives of
African American women (18-30 years) from the millennial generation towards hereditary breast
cancer mutations and PWT for hereditary breast cancer mutations. Given the current proposal for
PWT for hereditary breast cancer mutations, it is imperative that as researchers preemptively
assess the needs and perspectives of young African American women given the known breast
cancer disparity. Therefore, the purpose of this dissertation is to conduct a sequential exploratory
mixed methods study to understand young African American women’s perspectives towards
hereditary breast cancer mutations, PWT, DTC testing, and health communication preferences if
PWT became available in the future. This study also aims to understand the factors that impact
intentions to participate in PWT for hereditary breast cancer mutations in the future. The
specific aims research aims and hypotheses are as follows:

Aim 1: Identify knowledge gaps and attitudes (perceived disadvantages, advantages, subjective
norms, medical mistrust) towards genetic counseling for hereditary breast cancer mutations,
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motivators and barriers to participating in PWT for hereditary breast cancer mutations, health
communication preferences for PWT for hereditary breast cancer mutations among African
American women aged 18-30 years old, and perspectives about DTC genetic testing services.
Aim 1 Approach: African American women between the ages of 18 and 30 will be
recruited from Virginia Commonwealth University, Virginia Union University, and the
Greater Richmond area to participate in six focus groups (N~40) about knowledge and
perspectives of hereditary breast cancer mutations, willingness to participate in PWT,
health communication preferences for PWT, as well as perspectives about DTC genetic
testing services.
Aim 2: Examines the factors that influence young African American women’s intentions to
participate in PWT for hereditary breast cancer mutations.
Aim 2 Approach: African American women between the ages of 18 and 30 (N~ 160)
will be recruited using Qualtrics Online Sample to complete a survey about their
knowledge and perspectives of genetic counseling and testing for hereditary breast cancer
mutations, intentions to participate in PWT for hereditary breast cancer mutations, health
communication preferences, as well as perspectives about DTC genetic testing services.
Hypothesis 1: Participants will have low levels of knowledge about hereditary breast
cancer mutations and low levels of medical mistrust.
Hypothesis 2: There will be a positive relationship between participants’ attitudes
towards DTC testing and intentions to participate in PWT.
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Hypothesis 3: There will be a positive relationship between participants’ subjective
norms and intentions to participate in PWT.
Hypothesis 4: There will be a negative relationship between participants’ individual
medical mistrust and intentions to participate in PWT.
Hypothesis 5: There will be a negative relationship between participants’ group-based
medical mistrust and intentions to participate in PWT.
Hypothesis 6: There will be a positive relationship between participants’ perspectives
towards hereditary breast cancer mutations and intentions to participate in PWT.
Hypothesis 7: There will be a positive relationship between perceived risk of hereditary
breast cancer mutations and intentions to participate in PWT.
Hypothesis 8: There will be a negative relationship between participants’ perceived
severity of breast cancer and intentions to participate in potential population-wide testing.

Dissertation format
This aims of this study are presented in a three-paper format. All the papers provide an
understanding of the literature relevant to the aim, methods used, as well as a results and
discussion section.
(Aim 1): The first paper (Chapter 2) presents findings from the qualitative analysis of
focus groups with young African American women (students and community residents) that
aimed to explore their perspectives towards PWT in the U.S.
22

(Aim 2): The second paper (Chapter 3) provides insight into the factors that would impact
young African American women’s intentions to participate in PWT if offered in the future.
These findings were gathered through a quantitative analysis of an online survey distributed
through the Qualtrics Online Sample.
(Aim 3): The third paper (Chapter 4) utilizes health communication related findings from
Chapters 2 and 3 to create a data brief. The data brief, “Population-wide testing for Hereditary
Breast Cancer Genes: Recommendations for Public Health Practitioners to Reach and Raise
Awareness Amongst Young African American Women,” presents programming, training, and
public health campaign recommendations that public health practitioners at health departments
can use to best target and raise knowledge around PWT amongst young African American
women (18-30 years). The chapter provides and overview that presents the importance of closing
the translation gap between research and practice as well as the rationale for the brief. While
other chapters of this dissertation will be submitted to traditional academic journals, this brief
will be provided to key stakeholders at the Virginia Department of Health. It will also be
disseminated via Facebook through the Black Ladies in Public Health private Facebook group
that consists of over 10,000 public health practitioners.
The final chapter (Chapter 5) synthesizes the study findings as well as provides
implications for future research and practice.

23

References
Adams, I., Christopher, J., Williams, K., & Sheppard, V. (2015). What Black Women Know and
Want to Know About Counseling and Testing for BRCA1 / 2. Journal of Cancer
Education, 30(2), 344-352. doi:10.1007/s13187-014-0740-9
Afghahi, A., & Kurian, A. (2017). The Changing Landscape of Genetic Testing for Inherited
Breast Cancer Predisposition. Current Treatment Options in Oncology, 18(5), 1-10.
doi:10.1007/s11864-017-0468-y
Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the
use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
JAMA-J. Am. Med. Assoc., 293(14), 1729-1736. doi:10.1001/jama.293.14.1729
Bellcross, C. A., Kolor, K., Goddard, K. A., Coates, R. J., Reyes, M., & Khoury, M. J. (2011).
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J
Prev Med, 40(1), 61-66. doi:10.1016/j.amepre.2010.09.027
Bloss, C. S., Omowski, L., Silver, E., Cargill, M., Vanier, V., Schork, J. S., & Topol, E. J.
(2010). Consumer perceptions of direct-to-consumer personalized genomic risk
assessments. Genetics in Medicine, 12(9), 556. doi:10.1097/GIM.0b013e3181eb51c6
Bowen, S., & Khoury, M. J. (2018). Consumer Genetic Testing Is Booming: But What are the
Benefits and Harms to Individuals and Populations? Retrieved from
https://blogs.cdc.gov/genomics/2018/06/12/consumer-genetic-testing/
Carroll, N. M., Blum-Barnett, E., Madrid, S. D., Jonas, C., Janes, K., Alvarado, M., . . . BurnettHartman, A. N. (2019). Demographic differences in the utilization of clinical and directto-consumer genetic testing. Journal of Genetic Counseling. doi:10.1002/jgc4.1193
Churpek, J. E., Walsh, T., Zheng, Y., Moton, Z., Thornton, A. M., Lee, M. K., . . . Olopade, O. I.
(2015). Inherited predisposition to breast cancer among African American women. Breast
Cancer Res Treat, 149(1), 31-39. doi:10.1007/s10549-014-3195-0
DeSantis, C., Ma, J., Goding, A., Newman, L. A., & Jemal, A. (2017). Breast cancer statistics,
2017, racial disparity in mortality by state. CA: A Cancer Journal for Clinicians, 67(6),
439-448. doi:10.3322/caac.21412
Estrada, M. (2017). 23andMe’s DNA Test was a best-seller on Black Friday and it’s discounted
again for Cyber Monday. . Retrieved from https://www.yahoo.com/news/23andme-dnatest-best-seller-black-friday-discounted-130653190.html.
Force, U. S. P. S. T. (2019). Final Recommendation Statement: BRCA-Related Cancer: Risk
Assessment, Genetic Counseling, and Genetic Testing. Retrieved from
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStateme
ntFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing1
Foulkes, W. D., Knoppers, B. M., & Turnbull, C. (2016). Population genetic testing for cancer
susceptibility: founder mutations to genomes. Nat Rev Clin Oncol, 13(1), 41-54.
doi:10.1038/nrclinonc.2015.173
24

Hensley Alford, S., McBride, C. M., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C.
(2011). Participation in genetic testing research varies by social group. Public Health
Genomics, 14(2), 85-93. doi:10.1159/000294277
Hughes, C., Fasaye, G.-A., Lasalle, V. H., & Finch, C. (2003). Sociocultural influences on
participation in genetic risk assessment and testing among African American women.
Patient Education and Counseling, 51(2), 107-114. doi:10.1016/S0738-3991(02)00179-9
Institute, N. C. (2018 ). BRCA Mutations: Cancer Risk and Genetic Testing. Retrieved from
https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
Jones, T., Lockhart, J. S., Mendelsohn-Victor, K. E., Duquette, D., Northouse, L. L., Duffy, S.
A., . . . Katapodi, M. C. (2016). Use of Cancer Genetics Services in African-American
Young Breast Cancer Survivors. American Journal of Preventive Medicine, 51(4), 427436. doi:10.1016/j.amepre.2016.03.016
Jones, T., Trivedi, M. S., Jiang, X., Silverman, T., Underhill, M., Chung, W. K., . . . Crew, K. D.
(2019). Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among
Young Breast Cancer Patients. J Cancer Educ. doi:10.1007/s13187-019-01646-8
Kessler, L., Collier, A., Brewster, K., Smith, C., Weathers, B., Wileyto, E. P., & Halbert, C. H.
(2005). Attitudes about genetic testing and genetic testing intentions in African American
women at increased risk for hereditary breast cancer. Genet Med, 7(4), 230-238.
doi:10.1097/01.gim.0000159901.98315.fe
King, M.-C., Levy-Lahad, E., & Lahad, A. (2014). Population-based screening for BRCA1 and
BRCA2: 2014 Lasker Award. JAMA, 312(11), 1091. doi:10.1001/jama.2014.12483
Landry, L., Nielsen, D. E., Carere, D. A., Roberts, J. S., Green, R. C., & Group, P. G. S. (2017).
Racial minority group interest in direct-to-consumer genetic testing: findings from the
PGen study. J Community Genet, 8(4), 293-301. doi:10.1007/s12687-017-0325-5
Long, E. F., & Ganz, P. A. (2015). Cost-effectiveness of Universal BRCA1/2 Screening:
Evidence-Based Decision Making. JAMA oncology, 1(9), 1217.
doi:10.1001/jamaoncol.2015.2340
Malone, K. E., Daling, J. R., Doody, D. R., Hsu, L., Bernstein, L., Coates, R. J., . . . Ostrander,
E. A. (2006). Prevalence and predictors of BRCA1 and BRCA2 mutations in a
population-based study of breast cancer in white and black American women ages 35 to
64 years. Cancer research, 66(16), 8297. doi:10.1158/0008-5472.CAN-06-0503
Manchanda, R., & Gaba, F. (2018). Population Based Testing for Primary Prevention: A
Systematic Review. Cancers (Basel), 10(11). doi:10.3390/cancers10110424
McCarthy, A. M., Bristol, M., Domchek, S. M., Groeneveld, P. W., Kim, Y., Motanya, U. N., . .
. Armstrong, K. (2016). Health Care Segregation, Physician Recommendation, and Racial
Disparities in BRCA1/2 Testing Among Women With Breast Cancer. J Clin Oncol,
34(22), 2610-2618. doi:10.1200/JCO.2015.66.0019
NCCN, N. C. C. N. (2018). Genetic/ familial high-risk assessment: breast and ovarian 2018.
Retrieved from
https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
25

Pal, T., Bonner, D., Cragun, D., Monteiro, A. N. A., Phelan, C., Servais, L., . . . Vadaparampil,
S. T. (2015). A high frequency of BRCA mutations in young black women with breast
cancer residing in Florida. Cancer, 121(23), 4173-4180. doi:10.1002/cncr.29645
Petrucelli, N., Daly, M. B., & Feldman, G. L. (2010). Hereditary breast and ovarian cancer due
to mutations in BRCA1 and BRCA2. Genet Med, 12(5), 245-259.
doi:10.1097/GIM.0b013e3181d38f2f
Rubinsak, L. A., Kleinman, A., Quillin, J., Gordon, S. W., Sullivan, S. A., Sutton, A. L., . . .
Temkin, S. M. (2019). Awareness and acceptability of population-based screening for
pathogenic BRCA variants: Do race and ethnicity matter? Gynecol Oncol, 154(2), 383387. doi:10.1016/j.ygyno.2019.06.009
Sheppard, V. B., Graves, K. D., Christopher, J., Hurtado-De-Mendoza, A., Talley, C., &
Williams, K. P. (2014). African American Women's Limited Knowledge and Experiences
with Genetic Counseling for Hereditary Breast Cancer. Journal of Genetic Counseling,
23(3), 311-322. doi:10.1007/s10897-013-9663-6
Sheppard, V. B., Mays, D., Tercyak, K. P., & LaVeist, T. (2013). Medical Mistrust Influences
Black Women’s Level of Engagement in BRCA1/2 Genetic Counseling and Testing.
Journal of the National Medical Association, 105(1), 17-22. doi:10.1016/s00279684(15)30081-x
Thompson, H. S., Sussner, K., Schwartz, M. D., Edwards, T., Forman, A., Jandorf, L., . . .
Valdimarsdottir, H. B. (2012). Receipt of Genetic Counseling Recommendations Among
Black Women at High Risk for BRCA Mutations. Genetic Testing and Molecular
Biomarkers, 16(11), 1257-1262. doi:10.1089/gtmb.2012.0114
Yurgelun, M. B., Hiller, E., & Garber, J. E. (2015). Population-Wide Screening for Germline
BRCA1 and BRCA2 Mutations: Too Much of a Good Thing? Journal of clinical
oncology : official journal of the American Society of Clinical Oncology, 33(28), 3092.
doi:10.1200/JCO.2015.60.8596

26

Chapter 2
Paper 1
Young African American women’s perspectives of the potential shift towards population-wide
testing for hereditary breast cancer mutations: “We can do it, but just don’t take from us.”

27

Abstract
Young African American women (<50 years) are twice as likely than their White counterparts to
die from breast cancer. To promote breast cancer prevention, population-wide testing for
hereditary breast cancer mutations was proposed for women in the U.S. starting at age 30.
However, African American women currently utilize genetic testing for hereditary breast cancer
at lower rates than White women. The purpose of this study is to examine the perspectives of
African American women ages 18-30 towards population-wide testing for hereditary breast
cancer mutations with the goal of understanding how to prevent the current utilization gap from
widening if the new testing guidelines are adopted and to inform future health promotion
campaigns. We conducted seven focus groups with 39 young women residing in a southern
community and attending two local universities. Data was analyzed using a thematic analysis
approach. Findings indicate participants had limited knowledge of hereditary breast cancer
mutations but asserted that it was important for population-wide testing to be accessible to
everyone, normalized in American society, and to be thoroughly researched before it is presented
as a viable option to the general public. Motivators to participate in population-wide testing
included having a family history of breast cancer, access to equitable healthcare quality, and
concerns for future offspring. Barriers to intended participation in population-wide testing
included medical mistrust and concerns about affordability. Future health promotion campaigns
and research should determine how to normalize population-wide testing and increase
geographic and economic accessibility for young African American women
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Introduction
African American women continue to die from breast cancer at a higher rate than White
women. They are more likely to be diagnosed at earlier ages, with more advanced stages, and
with triple- negative breast cancer which is a highly aggressive form of the disease that lacks
targeted treatment (DeSantis et al., 2016; DeSantis, Ma, Goding, Newman, & Jemal, 2017;
Dietze, Sistrunk, Miranda-Carboni, O'Regan, & Seewaldt, 2015). Furthermore, African
American women under 40—who are younger than the recommended mammography screening
age—not only have the highest incidence of breast cancer, but they also have the highest
mortality rate of all racial groups (Anders, Johnson, Litton, Phillips, & Bleyer, 2009; Bleyer,
O’Leary, & Ries, 2006). Finding ways to reduce these disparities is a pressing public health
concern.
Genetic testing for hereditary breast cancer mutations provides a unique pathway to
prevention and treatment of breast cancer, especially among African American women (Force,
2019). Hereditary breast cancer accounts for between 5 and 10 percent of all breast cancers
(Force, 2019). However, African American women who meet the current hereditary breast
cancer mutation counseling and testing profile utilize genetic counseling services at lower rates
than their White women, making prediction of rates in this population difficult (Peterson et al.,
2020). Researchers found that 20% of African American women with triple negative breast
cancer had a BRCA1/2 mutation (Breast cancer 1 and Breast cancer 2 mutations) and that those
diagnosed with triple-negative breast cancer at younger ages had an even higher percentage of
BRCA1/2 mutations (Pal et al., 2015). Further, they found that 22 percent of the African
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American women under the age of 35 had a BRCA1/2 mutation (Pal et al., 2015). Another
retrospective cohort study with young women with early onset of breast cancer found that
African American women had the highest prevalence of hereditary breast cancer mutations
(18.2%) in their sample(Jones et al., 2019). The presence of hereditary breast cancer mutations in
African American women is important because mutation carriers have an elevated risk of
developing breast cancer from 40-80% over their lifetime, compared to the average lifetime risk
of 12% (DeSantis et al., 2017; Kuchenbaecker et al., 2017; Petrucelli, Daly, & Feldman, 2010).
Hereditary breast cancer mutation carriers are also typically diagnosed with breast cancer at early
ages, and BRCA1 mutation carriers, specifically, are largely diagnosed with triple-negative breast
cancer (Chen et al., 2018).
Current recommendations for genetic counseling and testing for hereditary breast cancer
mutations from the National Comprehensive Cancer Network (NCCN) states the necessity of
either a family or personal cancer history suggestive of having a hereditary breast cancer
mutation (Force, 2019; Institute, 2018 ). However, given recent study findings indicating that the
current screening criteria are not capturing all women with hereditary breast cancer mutations,
there has been a call for population-wide testing (PWT) for all women in the United States
starting at age 30 (King, Levy-Lahad, & Lahad, 2014). This potential shift in screening
recommendations would remove the need to rely on an individual’s knowledge of their family
history and the need for physician recommendation for testing for hereditary breast cancer
mutations (King et al., 2014). Lack of physician recommendation for screening has consistently
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been cited as a major contributor to African American women’s lower rates of utilization of
genetic testing for hereditary breast cancer mutations (Armstrong, Micco, Carney, Stopfer, &
Putt, 2005; McCarthy et al., 2016; Peterson et al., 2020). Therefore, if implemented, the potential
benefits of PWT need to be communicated to all women, but especially to younger African
American women, given the breast cancer disparity that disproportionately impacts them.
Existing research has focused on the perspectives and knowledge levels about hereditary
breast cancer mutations of African American women (<40) with a family or personal history of
breast cancer suggestive of a mutation (Adams, Christopher, Williams, & Sheppard, 2015;
Hughes, Fasaye, Lasalle, & Finch, 2003; Hurtado-de-Mendoza, Jackson, Anderson, & Sheppard,
2017; Kessler et al., 2005; Sheppard et al., 2014; Sheppard, Mays, Tercyak, & LaVeist, 2013).
Lack of knowledge, high cost of testing, medical mistrust, limited access to healthcare, and lack
of physician recommendation fuels their lower utilization of genetic counseling services (Adams
et al., 2015; Hurtado-de-Mendoza et al., 2017; McCarthy et al., 2016; Sheppard et al., 2014;
Sheppard et al., 2013; Thompson et al., 2012). However, not much research has focused on
capturing the perspectives of hereditary breast cancer mutations of African American women
without a family history suggestive of a hereditary breast cancer mutation(Adams et al., 2015),
and only one study has captured their attitudes about PWT for hereditary breast cancer mutations
(Rubinsak et al., 2019). Further, to date, no studies have focused on the perspectives of young
women, particularly young African American women, about this potential shift towards PWT
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despite their heightened risk for early onset of breast cancer and triple negative breast cancer
compared to other racial groups.
The millennial generation of African American women born between 1982 and 2004
came of age during the technology revolution and, most recently, during the rise of direct-toconsumer genetic testing that can be used to provide answers about their ancestry and health
without the need for a physician recommendation. Direct-to-consumer genetic testing services
(DTC testing), such as Ancestry.com and 23andMe, are steadily increasing in popularity in the
United States (Bowen & Khoury, 2018). To date, there have been a limited number of studies
that provide insight into DTC testing uptake and the perspectives of racial minorities on DTC
testing (Bloss et al., 2010; Carroll et al., 2019; Hensley Alford et al., 2011; Landry et al., 2017).
These studies have found that African Americans use DTC testing at similar rates as their White
counterparts and are more interested in using these services to learn about their ancestry than
disease information (Carroll et al., 2019; Landry et al., 2017). However, none have focused
specifically on young African American women’s perspectives of DTC testing services in
relation to genetic counseling and testing for hereditary breast cancer mutations. There are
distinct differences between DTC testing and population-wide testing in that DTC testing is
largely handled by private companies whereas PWT would be implemented by the healthcare
system. Despite these differences, young African American women’s perspectives on an already
widely available genetic counseling and testing service, such as DTC testing, could provide
further insight into their perspectives about PWT in the future.
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Understanding why people do or do not engage in health protective behaviors should be
informed by appropriate theoretical frameworks. The Integrative Behavioral Model provides a
robust framework to best understand young African American women’s perspectives of DTC
testing, genetic counseling and testing for hereditary breast cancer mutations, and PWT in the
future (Fishbein & Cappella, 2006). This theory posits that the most salient determinant for an
individual to perform a health behavior is behavioral intention (Glanz, Rimer, & Viswanath,
2015). Furthermore, it states that an individual’s intentions to perform a behavior are influenced
by their perceived norms, attitudes, environmental constraints, knowledge, habits, perceived
importance of the behavior, and their personal agency (Fishbein & Cappella, 2006; Glanz et al.,
2015). The purpose of this paper is to address this significant gap in the literature by using the
Integrative Behavioral Model to examine the perspectives of African American women from the
millennial generation (ages 18-30) towards PWT for hereditary breast cancer mutations who, if
PWT was implemented, would be coming of age during this shift.
Methods
Focus groups were conducted as part of a larger sequential exploratory mixed methods
study to inform the development of a survey on the same topic. To obtain a more representative
sample to inform the development of the larger online survey, focus group participants included
women who were university students and community-based residents not attending college. A
multi-prong convenience sampling approach using flyers, social media, emails, and word of
mouth was used to recruit focus group participants in the Greater Richmond Area, including at
Virginia Commonwealth University and Virginia Union University. The recruitment messages
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provided information about the opportunity to discuss African American young women’s
perspectives of hereditary breast cancer mutations and their health communication preferences.
Participant inclusion criteria included: a) women who self-identified as African American and/or
Black; b) between the ages of 18 and 30; c) residence in the Greater Richmond area, and/or)
enrolled in undergraduate or graduate studies at either Virginia Commonwealth University or
Virginia Union University. We conducted seven focus groups (n=39). Four focus groups were
conducted with community residents and three with students from Virginia Commonwealth
University or Virginia Union University. This study was approved by the Institutional Review
Board at Virginia Commonwealth University (HM200015881).
Procedure
Upon arrival to the focus group, participants were provided an information sheet which
included the study purpose, voluntary nature of their participation, minimal risks associated with
their participation, payment for participation, and encouraged participants to ask any questions.
Focus groups were conducted by the first author. The first author, an African American female,
who is currently a PhD candidate in Social and Behavioral Sciences, has extensive training and
experience in conducting focus groups. Focus groups were conducted between July and October
2019 and lasted approximately 30 to 45 minutes. The focus groups were hosted in the afternoons
to best accommodate both students and community members’ schedules. Participants also
completed a demographic survey after reading the study information sheet. The demographic
survey included questions about residency, age, racial and ethnic background, marital status,
employment status, college enrollment status, and family history of breast cancer. Both
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community and student focus groups were held in private rooms at Virginia Commonwealth
University and Virginia Union University. Participants received a $15 Target gift card upon
completion of the focus group.
Instrumentation
Using semi-structured questions developed informed by the Integrative Behavioral
Model, the focus group guide elicited participants’ knowledge of hereditary breast cancer
mutations as well as their perspectives towards DTC testing, genetic counseling and testing for
hereditary breast cancer mutations, and PWT in the future. The moderator guide began the group
by reading a short introductory question: “Companies, such as 23andme and Ancestry.com, now
offer genetic testing to the public for a small fee that provide information about the links between
their genetic information and their health: What do you think of these services? Examples of
questions included in this analysis are: What, if anything, have you heard about the hereditary
breast cancer mutations? What do you think are the advantages of undergoing genetic
counseling and testing for hereditary breast cancer mutations? What do you think are the
disadvantages of undergoing genetic counseling and testing for hereditary breast cancer
mutations? Participants were also asked about their perspectives and motivations about
participating in any future potential shift towards PWT for hereditary breast cancer mutations
including: What do you think about the potential shift towards PWT for hereditary breast cancer
mutations? What would motivate you to participate in PWT for hereditary breast cancer
mutations? What would deter you from participating in PWT for hereditary breast cancer
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mutations? All focus groups were audio-recorded and transcribed verbatim by a professional
transcription service, Rev.com.
Data Analysis
SPSS was used to analyze quantitative demographic data. Focus groups were analyzed by
the first author (AH) and a graduate student, both of whom are trained in qualitative analysis.
Coders conducted a thematic analysis of the data using MAXQDA software (Braun & Clarke,
2006). The primary author created a preliminary codebook by reading and re-reading the
transcripts to search for patterns in the data and subsequently created initial codes. These patterns
and initial codes were organized around the focus group questions. After the creation of the
preliminary codebook, both coders read and assigned codes to each transcript independently.
Coders met weekly to refine existing codes, add any additional codes emerging from the data,
finalize the codebook, and reach consensus on any coding discrepancies. Overarching themes
were created using the constant comparative method of grouping and ordering codes.
Results
The majority of the participants identified themselves as Black or African American
(97.4%) with only one participant identifying as Black and Hispanic (2.5%), and the majority
lived either in Richmond City (59%) or Henrico County (23%). Most participants were
unmarried (94.9%), had full-time employment (76.9%), and were enrolled in college (64.0%).
Most were either college freshmen (12.8%), juniors in college (10.3%), seniors in college
(15.4%), or graduate students (17.9%). Lastly, there were slightly more participants without a
family history of breast cancer (53.8%) than participants with a family history (46.2%).
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Five overarching themes emerged from the focus group discussions: 1) perceived benefits
and barriers to participating in direct to consumer testing (DTC testing); 2) limited knowledge
about hereditary breast cancer mutations; 3) perceived advantages and disadvantages of testing
for hereditary breast cancer mutations; 4) motivators and barriers to participating in PWT; and 5)
concerns prior to rolling out PWT to the general public.
Benefits and barriers to participating in direct to consumer testing. Participants
expressed benefits including helping them to connect with family members and providing
information about their health risks to participating in DTC testing services, such as
Ancestry.com and 23andMe. Some participants described these services as a helpful resource to
connect them with other family members. One participant commented:
“I used Ancestry.com, and I really liked knowing some type of association of where my
family history was. I did like being able to see what types of tribes were mixed in my
blood, and mixed and mingled. It allowed me to connect with family members I had no
idea existed.”
Other participants mentioned the utility of using these online testing services to provide
them with information about their health and risk factors for disease. One participant stated:
“I think in theory, that’s super helpful, and I have a history of breast cancer in my family,
so for me it feels like if I’m genetically predisposed. Then I agree there are external
factors that influence our health for sure, but to know that, oh, okay, there’s something in
my body that leaves me more likely, than I feel like I would want to know.”
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Participants also expressed environmental constraints surrounding DTC testing.
Participants expressed concerns about both the accuracy and confidentiality of their results. One
participant commented: But personally I wouldn’t try it because ... I’m a really paranoid person.
“So yeah, they say it goes... but do we really know? And could the results even be that
accurate?” Another participant indicated that she had doubts about who would be reviewing the
results: “So you and I feel like it’s not really guaranteed that there’s a specific doctor looking at
those tests. Like you’re sending it to somebody on the internet.”
Participants also highlighted concerns about the confidentiality of their genetic
information if sent to a DTC testing company. One participant stated:
“Yeah I’ve always heard about the 23andMe, the whole government thing. I guess
they’re watching you, they’re keeping track of what you’re doing, putting you in the
system. So I’ve always been kind on the fence about it, but being a biology major, I feel
like it could be good.”
Another participant connected her concerns about the confidentiality of her genetic information
to how it could be used to negatively impact her in the future as Black person in America: “My
thing like the way black people are being set up like, “Oh, we found your DNA at this scene.”
I’m like, how? I wasn’t there.”
Limited knowledge about hereditary breast cancer mutations. Many participants either
had no knowledge or limited knowledge about hereditary breast cancer mutations. Some
participants responded that they had not heard anything about the hereditary mutations including
this participant: “I honestly have not heard anything about it.” Many participants highlighted
39

hearing about the hereditary nature of the mutations and having a partial understanding of the
mutations. A participant commented:
“I haven’t heard much of it, honestly. I just know that breast cancer can sometimes be
hereditary in your family and some family members take precautions with their children
at young ages to make sure that they don’t go through that.”
Other women highlighted what they have learned from either their own or a friend’s family
history of breast cancer. One woman stated:
“Yeah, I don't really know what that means to be honest. I'm not even gonna lie. I've
never heard of mutation, or I don't know what that is, but I've just heard my grandmother
had breast cancer and so when I was like 17 or 18, we all go to the same doctor, me, my
grandmother and my mom. So my doctor would always tell me ... She would always like,
you know, when you get your Pap, she would check my breasts and tell me how to do it at
home. But as far as the mutation, I don't really know.”
Interestingly, despite having limited knowledge about the hereditary breast cancer mutations, a
few participants referenced the heightened risk of breast cancer amongst African American
women. A participant said:
“Breast cancer doesn't run in my family, but I have friends whose moms have had it. So
they get tested often. I've got people I know that it's literally been like "Grandma had it.
So my aunt had it." And so I do know that black, well this might be incorrect, but black
women can get some of the most aggressive forms of breast cancer.”
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Perceived advantages and disadvantages of testing for hereditary breast cancer
mutations. Many participants mentioned many advantages to testing for hereditary breast cancer
mutations including early detection, being informed, and potential lifestyle changes. Participants
consistently highlighted the importance of early detection of breast cancer as an advantage of
genetic counseling and testing for hereditary breast cancer mutations. One participant
commented:
“But you go to the eye doctor and they ask you to do that extra test. That extra test can
save you from glaucoma and stuff like that. So that extra test for breast cancer mutations,
can help you for your future instead of later on down the road. You’re now sick and can’t
really do anything.”
In a similar vein, these participants also cited the importance of being informed about their risk
for breast cancer in the future as an advantage of genetic counseling and testing for hereditary
breast cancer mutations. One participant commented:
“I really think it’s just a matter of being better informed because, I mean science is
advancing at a rate that’s out of this world these days. But I feel like there’s still a lot of
things that go under the radar in terms of scans and all of those things that just go unseen
and I think genetic testing would just give a leg up in terms of knowing a little bit more
when it comes to things that may be going on that you can’t see.”
Some also noted the importance of being informed about their hereditary breast cancer mutation
status as it relates to their future childbearing decisions. One participant stated: “So with the
breast cancer, not so much the partner part, but as far as okay, I know I carry this gene. So if I
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have a child it may pass on to my child. Do I want to do that? It lets you have options at least
upfront.”
Participants also pointed to the lifestyle changes that could be made based upon their
knowledge of the hereditary breast cancer mutation status. One participant commented: “Now I
would want to make sure that I’m living a certain lifestyle in order to prevent certain things to
enter into my body, or for our body to mutate in any other way. I feel like that kind of
information would be important to me.”
Participants cited multiple disadvantages to undergoing genetic counseling and testing for
the hereditary breast cancer mutations. Some women mentioned the fear that they have around
getting testing for hereditary breast cancer mutations. One participant commented:
“I feel like it could definitely scare somebody a lot. Yeah, we said it would be informative
to let your kids know and stuff like that, but a lot of people could go about that as
completely changing their lives, and just never fully living to the best of their ability
because they’re like, Oh, what if I die because of breasts… You have that in the back of
your head the whole time.”
Others mentioned the potential impacts of finding out that they have a hereditary breast cancer
mutation on their mental health. One participant stated: “It may make me live a healthier
lifestyle. But I could totally see just slipping into depression about my fate and all of that. Yeah
because I would worry all the time too.”
Medical mistrust of genetic counseling and testing for hereditary breast cancer mutations
were constraints for some participants. Some participants expressed mistrust of the accuracy of
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the test results and concerns about the privacy of their genetic information. One participant
stated: “What if they make a mistake? They were wrong or something. I’ve chopped off both my
breasts. Can’t take that back. So it definitely would impact your life from now on.” Another
participant mentioned being afraid that her genetic information would be used to create a “clone”
in the future.
Some participants wondered how they would be able to afford to get the testing and
whether it would be included in their current insurance plans:
“I feel like one, it just depends on how much they’re going to incorporate in people’s
insurance plans. Are you going to have to come out of pocket? I’m just trying to do that
cause, because at this point, I would like to but it’s like, I’m not really sure.”
Motivators and barriers to participating in potential PWT. When asked about what
would motivate them to participate in PWT, they identified multiple factors including, family
history of breast cancer, healthcare quality, and being informed for themselves and their current
and future family. Having a family history of breast cancer was a strong motivator to participate
in PWT. One participant commented:
“I would do it. My motivations are my health, and recognition of family history... and two
people, it's not a lot of people, but it's more than enough people to feel like that they're
not too many generations removed. So, if there is a genetic component to it, then I would
want to know. I would be in the room shaking and probably, like, somebody hold my
hand, but I think that would be enough motivation to get me to go.”
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Belief that they would receive quality health care would also be a motivator for some
participants. One participant said:
“I think if I was to know that I would be treated like an individual because a lot of time
they like to branch us all into one cure all for everyone, and that's not the case because
everybody is different. So, as long as I know somebody is going to cater to my needs, not
a group of people.”
Having children was also identified as a motivating factor in their participation in PWT for
hereditary breast cancer mutations. One participant said:
“I'm just a wild card out here in these streets. I think I'd probably be more motivated if I
had children, if I'm being honest. If I had a little girl or a little boy, but more specifically
a little girl, who I was raising, and I wanted to protect them at all costs... I think that
would probably be a huge motivation for me; and it's probably currently a huge
motivation for a lot of women in taking care of themselves and getting checked out.”
Medical mistrust particularly related to health care quality, provider competence,
accuracy of diagnosis, confidentiality, as well as appropriate usage of genetic information was
mentioned by several participants as barriers to participating in population-wide testing. One
participant stated:
“I would just be more concerned kind of saying what you got to say is that the person
who's doing it is skilled and educated enough to know what they're doing. Because if it is
something so new, I'm sure people can be getting misdiagnosed all over the place.”
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Another participant pointed to the importance of African American’s not being exploited during
the roll out of PWT: “I'm all for it. If it doesn't disenfranchise us. I'm over that. I think everyone
at this [point] is over that. So we can do it, but just don't take from us.”
Affordability of the testing would be a major deterrent to their participation in PWT. One
participant stated: “If it comes with a cost that we cannot afford, don't offer me that. That's like a
spit in my face.” Similarly, insurance coverage in their decision and ability to participate in
PWT: “If my insurance doesn't cover it and it's a lot of money, I probably wouldn't do it unless I
absolutely needed to.”
Concerns prior to rolling out PWT. Participants also highlighted concerns about the rollout of PWT to the general public that they believed should be considered. Many of the
participants were concerned about potential access barriers including how inclusive and
accessible the rollout would be to underrepresented ethnic and racial groups and socioeconomically disadvantaged groups. For instance, one participant stated:
“I mean you already know so much going on right now with healthcare, and it seems like
the more and more that things become available to everyone, specifically for African
Americans. And I’m not saying by any means like we should be exclusive, but I just see
an issue arising with it not being the same. What’s to say that if you say genetic
counseling across every single state, Virginia is going to have the same set up as
California? Are we going to have the same access to different resources?”
Another participant pointed to the concern for access for individuals who are socio-economically
disadvantaged: “When you think of doctor visits, you have to think about people who have access
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to health care. So in my mind, I’m wondering if certain populations will get more help with this
type of thing than others. Because they have more access to go to the doctor and talk to
someone.”
Some participants also pointed to the newness of genetic counseling and testing for
hereditary breast cancer mutation and the need for additional research for them to be comfortable
with participating. One participant commented:
“Once again I don’t know why my brain is going this way, but I think about the HPV
shots. When the first came out, my mom was like “You’re not getting that. It needs to be
tested more, and this, this that and the other.” And I think it’s going to be the same way if
that is brought up population-wide.”
Along this vein, participants also spoke about the need to integrate PWT in both the medical
field and society at large if it is to be successful. One participant stated:
“I think you could probably be like integrated more into your pediatric care. Like how
your physician tells you, “Oh, you got to take this for if you’re having sex or if you’re
sexually active and all that. But no one ever touches the topic of breast cancer at all. It’s
just never really talked about as you get older until, you reach a certain age, and it’s like.
“Oh, I guess I should get a mammogram.”
Other participants highlighted the need for PWT to become more of a “mainstream thing” first,
before it is likely to have any traction amongst young black women.
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Discussion
This current study examined the perspectives of young African American women (ages
18-30) about genetic counseling and testing if there was to be a shift towards PWT in the United
States. Given existing breast cancer and genetic counseling and testing utilization disparities, it
is imperative to understand the perspectives of millennial African American women about this
potential shift in testing guidelines. This group has largely been absent from conversations
around genetic counseling and testing for hereditary breast cancer mutations unless they were
breast cancer survivors themselves (Jones et al., 2016). The potential of PWT for genetic
counseling and testing for hereditary breast cancer mutations for every woman regardless of
family history, beginning at age 30, appears to be imminent (Buchanan et al., 2020; King et al.,
2014). Therefore, the perspectives of African American women between the ages of 18 and 30
who have not been affected by breast cancer provide key insights into potential knowledge gaps,
attitudes, and environmental constraints that can be addressed in the development of future PWT
interventions with this population.
This is the first known study to explore young African American women’s perceptions of
seeking information about their health risks and ancestry through direct to consumer testing
platforms such as, 23andMe and Ancestry.com. Participants in this study identified multiple
benefits and barriers to utilizing existing DTC testing services. Similar to prior research findings,
participants in this study also indicated that DTC testing services are useful to connect them with
other family members and to learn about their health (Carroll et al., 2019; Landry et al., 2017).
Consistent with prior research on African American women’s perspectives of traditional clinical
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genetic testing, cost and medical mistrust were major environmental constraints to DTC testing
(Sheppard et al., 2013). Participants also expressed concerns about accuracy and confidentiality
of their test results from DTC testing companies.
Consistent with prior studies, participants had limited knowledge of hereditary breast
cancer mutations (Adams et al., 2015; Sheppard et al., 2014). If PWT is made available, this
finding highlights the need for greater education in this group about hereditary breast cancer
mutations. Hurtado de Mendoza et al. (2017) found that knowledge is a key factor impacting
genetic counseling and testing engagement amongst African American women at high risk for
being a hereditary breast cancer mutation carrier (Hurtado-de-Mendoza et al., 2017). Therefore,
education about hereditary breast cancer mutations will need to be a key component in health
communication messaging and the design of future PWT interventions with this group.
Participants had similar perceived advantages and disadvantages of current model of
genetic counseling and testing for hereditary breast cancer mutations as African American
women in prior studies (Adams et al., 2015; Sheppard et al., 2014; Sheppard et al., 2013).
Benefits of testing, such as early detection, being informed about their carrier status, and
potential lifestyle changes that they could make if they possess the gene, mirror those found in a
previous study with African American women in Washington, D.C (Adams et al., 2015). Similar
to past studies (Adams et al., 2015; Sheppard et al., 2013; Sutton, He, et al., 2019), the
participants in this current study also indicated that medical mistrust would be a major barrier to
their participation in traditional genetic counseling and testing for hereditary breast cancer
mutation. These women expressed concerns not only about the accuracy of the test but also the
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confidentiality of their test results. A recent study found that African American women had
moderate levels of confidence in the Genetic Information Non-Discrimination Act (Sutton,
Henderson, et al., 2019). However, the concerns surrounding data confidentiality expressed by
participants may be related to a lack of knowledge of GINA and its protections amongst African
American millennial women.
When asked specifically about the potential shift towards population-wide availability of
testing for hereditary breast cancer mutations, participants were concerned about possible
disparities in screening practices amongst underrepresented racial and ethnic groups and socioeconomically disadvantaged groups that could occur if PWT becomes widely available. They
were hyper-aware of the potential widening of disparities that could occur due to existing
inequities as it relates to differential medical screening practices and quality of care based on
race and socio-economic status. Given the current shortage of genetic counselors, access to these
services would be an important concern, especially in underserved communities (Bookman &
News, 2016). Similar to the disadvantages that participants highlighted in reference to the
current model for genetic testing for hereditary breast cancer mutations, medical mistrust and
affordability continue to be significant barriers to their participation in PWT for hereditary breast
cancer mutations.
Limitations and Future directions
One limitation to the current study is that this was a convenience sample of primarily,
college students at 31.6% of the community group were also college students. Therefore, the
findings from this study may not represent the perspectives of non-college attending African
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American women. This group may face additional barriers, including lack of access to a genetic
counselor and competing priorities, that prevent them from participating in PWT. Future
research should examine the perspectives of low income African American millennial women to
explore whether their perspectives of PWT may differ from the women in this study. Another
limitation was that the young women’s intentions to participate in PWT was not directly assessed
during the focus groups. However, factors that impact their willingness to participate according
to the Integrative Behavioral Model were probed (i.e. motivators, barriers). Future research needs
to examine the factors that influence young African American women’s intentions to participate
in PWT in the future.
Implications
This study has implications for existing health care policies surrounding genetic
counseling and testing for hereditary breast cancer mutations. Given the participants’ concerns
about the cost of PWT, policies will be need to be created that make PWT accessible for all. The
Affordable Care Act currently addresses the cost of genetic counseling and testing for women
who are considered to be at high risk for being BRCA1/2 mutation carrier (Walcott & Dunn,
2015). However, the cost of genetic counseling and testing for women who do not meet the
screening guidelines for traditional genetic counseling and testing for BRCA1/2 is not covered
(Walcott & Dunn, 2015). Policymakers will need to extend this policy to cover all women in the
U.S. if PWT is implemented in the future. The Affordable Care Act currently lacks the provision
of coverage for risk-reducing interventions including, chemoprevention, frequent
mammography, and preventive double mastectomy, that are the recommended next steps for
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patients who find out that they carry a hereditary breast cancer mutation (Walcott & Dunn,
2015). This is an important missing provision under the current guidelines, however if PWT is
implemented in the United States, it will be critical that this provision is added and made
available to all women but especially to young African American women who have concerns
about the affordability of PWT in the future.
This study also has implications for genetic counselors who will be a part of the PWT
process. Given the high levels of medical mistrust expressed by women in this study, genetic
counselors will need to have cultural competency training as well as learn strategies to build trust
with members of this population. Prior implicit bias simulation research by Schaa et al. (2015)
with genetic counselors indicated that most genetic counselors in their study had either a
moderate or strong pro-White bias (Schaa, Roter, Biesecker, Cooper, & Erby, 2015). This proWhite bias led to genetic counselors in the study not building rapport and being verbally
dominant in conversations with simulated Black clients (Schaa et al., 2015). Addressing potential
biases amongst genetic counselors will be particularly helpful in improving health
communication and building trust with African American patients.
Conclusion
African American women continue to be disproportionately impacted by breast cancer
and are more likely to succumb to the disease than any other racial group. Population-wide
testing is a potential pathway to breast cancer prevention for young African American women in
the United States. However, if long standing barriers facing the African American community,
such as lack of knowledge about hereditary breast cancer mutations, cost, and medical mistrust
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are not addressed, then the genetic counseling and testing utilization gap will only continue to
widen. Targeted health promotion programs will need to be implemented to increase knowledge
of hereditary breast cancer mutations, the Genetic Information Non-Discrimination Act, and to
help with visibility of PWT within this population. Policies will also need to be amended and
created to provide insurance coverage for not only genetic counseling and testing but also any
risk reducing interventions that are necessary for hereditary breast cancer mutation carriers.
Furthermore, medical mistrust is a particularly important barrier that will need to be addressed
by cultural competency trainings and the recruitment of African American students into the
genetic counseling profession. Lastly, issues of access will also need to be addressed to
determine how such a service could be economically and geographically accessible for all.
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Chapter 3
Paper 2
Predictors of young African American women’s intentions to participate in potential populationwide testing for hereditary breast cancer mutations
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Abstract:
Young African American women (<40 years) are twice as likely to die from breast cancer than
White women. Preventive efforts, including population-wide testing for hereditary breast cancer
mutations for all women in the United States beginning at age 30, are being considered as
potential pathways to breast cancer prevention for all women. This paper examines factors that
influence intentions to participate in potential population-wide testing in a sample of 170 African
American women. Participants in this study were between the ages of 18 and 30 and did not have
a known hereditary breast cancer mutation. Simple and multiple regression models assessed the
relationship between factors and participants’ intentions to participate in population-wide testing.
Participants had moderate knowledge levels of hereditary breast cancer mutations and moderate
to high levels of medical mistrust. Simple regressions indicated that subjective norms (B = .460,
p = .000) and motivators to participate in direct to consumer testing (B = .217, p = .004) were
positively associated with intentions to participate in potential population-wide testing.
Subjective norms (B = .449, p = .000) and motivators to participate in direct to consumer testing
(B = .204, p =.009) remained significant after accounting for sociodemographic variables.
Findings suggest that family-based and social network interventions as well as public health
campaigns that target social networks would be particularly well-suited for this population.
Furthermore, it will be important to better understand the linkages between young African
American women’s current participation in direct to consumer testing and their intentions to
participate in population-wide testing.
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Introduction
African American women are most likely to die from breast cancer at every age when
compared to White women (DeSantis et al., 2019; Society, 2020). Breast cancer amongst young
women is rare. However, young African American, who are younger than the recommended
mammography screening age (< 40 years), are twice as likely to die from breast cancer, have the
highest incidence of breast cancer of all racial groups, and the highest rates of an aggressive form
of breast cancer, triple negative breast cancer (Anders, Johnson, Litton, Phillips, & Bleyer, 2009;
Bleyer, O’Leary, & Ries, 2006; DeSantis et al., 2019; Dietze, Sistrunk, Miranda-Carboni,
O'Regan, & Seewaldt, 2015). Triple negative breast cancer lacks proper treatment and is
associated with the presence of a hereditary breast cancer mutation. Studies with young African
American women with breast cancer have consistently indicated that they have a high prevalence
of hereditary breast cancer mutations (Jones et al., 2019; Pal et al., 2015). African American
women who meet current screening recommendations for hereditary breast cancer mutations
utilize genetic counseling and testing services at lower rates than White women (Armstrong,
Micco, Carney, Stopfer, & Putt, 2005; McCarthy et al., 2016). Recently, there has been a
growing interest in expanding hereditary breast cancer mutation screening to all women
beginning at age 30 in the United States to promote breast cancer prevention (King, Levy-Lahad,
& Lahad, 2014); however, if implemented it is imperative to ensure that such screening does not
widen existing breast cancer disparities impacting young African American women.
Hereditary breast cancer mutations account for approximately 5 to 10 percent of all breast
cancers (Force, 2019). The average lifetime risk of breast cancer amongst women is 12%;
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however, hereditary breast cancer mutation carriers have an increased lifetime risk of breast
cancer of between 40 and 80 percent (Kuchenbaecker et al., 2017; Petrucelli, Daly, & Feldman,
2010). Similar to the experiences of African American women with breast cancer, hereditary
breast cancer mutation carriers are typically diagnosed at younger ages and with triple negative
breast cancer (Chen et al., 2018). Hereditary breast cancer mutation carriers have preventative
options available to them including, more frequent mammography screening, chemoprevention,
and mastectomy to reduce their risk of developing breast cancer (Force, 2019). However, given
their lower rates of testing, African American women, who meet the current screening
guidelines, have largely not been able to reap the preventive benefits of genetic counseling and
testing for hereditary breast cancer mutations.
More recently, there has been an increasing call for population-wide testing (PWT)
largely prompted by recent studies indicating that up to 50 percent of hereditary breast cancer
mutation carriers are missed with current screening criteria (King et al., 2014; Manchanda,
Loggenberg, et al., 2015). Current screening guidelines from the National Cancer
Comprehensive Network (NCCN) requires a personal or family history suggestive of a
hereditary breast cancer mutation to be eligible for genetic counseling and testing (Force, 2019;
Institute, 2018 ). However, PWT would eliminate this current model that hinges on physicians as
gatekeepers to genetic counseling and testing for the mutations (King et al., 2014). Prior studies
have indicated that PWT is cost-effective given the decreasing prices of genetic testing and that
there is high interest amongst women in in this potential initiative (Manchanda & Gaba, 2018;
Manchanda, Legood, et al., 2015; Rubinsak et al., 2019). If PWT were to be implemented, this
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potential shift could be transformative for breast cancer prevention among African American
women given that formative data has consistently linked the lower utilization of genetic
counseling and testing for hereditary breast cancer mutations by African American women, who
meet current NCCN testing guidelines, to the lack of physician referral for genetic counseling
and testing (McCarthy et al., 2016). Other commonly cited barriers to their participation in
genetic counseling and testing are lack of knowledge about hereditary breast cancer mutations,
cost, medical mistrust, and concerns about their families’ negative perceptions towards
participation in genetic counseling and testing (Adams, Christopher, Williams, & Sheppard,
2015; Hurtado-de-Mendoza, Jackson, Anderson, & Sheppard, 2017; Sheppard et al., 2014;
Sheppard, Mays, Tercyak, & LaVeist, 2013). Prior to rolling out PWT, it will be important to
preemptively understand and address any barriers that young African American women may
experience to participating in PWT.
There is a lack of research focusing on the perspectives of young African American
women, who do not have a family history suggestive of a hereditary breast cancer mutation,
towards genetic counseling and testing for hereditary breast cancer mutations. Currently, only
one study includes African American women’s perspectives towards and acceptability of PWT;
however, the mean age of participants in this study was 37.7 (Rubinsak et al., 2019). Moreover,
there have not been any studies that focus on the factors that influence young African American
women’s intentions to participate in PWT if it becomes available in the future. Young African
American women between the ages of 18 and 30 are unique in that they have come of age during
the rise of direct to consumer testing (DTC) services, such as Ancestry.com and 23andMe, which
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are already widely available genetic testing services that provides information about health
without the need for a physician recommendation. Studies indicate that African Americans
utilize DTC testing at similar rates as Whites, however none have explored whether young
African American women’s intentions to participate in PWT for hereditary breast cancer
mutations are influenced by their perspectives toward DTC testing (Carroll et al., 2019; Landry
et al., 2017). Understanding the potential factors that influence young African American
women’s intentions to participate in PWT will provide insight into behavioral interventions and
public health campaigns for this group.
The Integrative Behavioral Model provides a comprehensive framework to understand
the factors that influence young African American women’s intentions to participate in PWT for
hereditary breast cancer mutations. This theory indicates that the most important determinant for
a person’s intentions to perform a health behavior is behavioral intention (Fishbein & Cappella,
2006). Furthermore, it states that an individual’s intentions to perform a behavior are influenced
by their perceived norms, environmental constraints, knowledge, habits, attitudes, and their
personal agency (Fishbein & Cappella, 2006). This current paper aims to examine the factors
that influence young African American women’s (ages 18-30) intentions to participate in PWT
in the future. The main hypotheses for this study are:
Hypothesis 1: Participants will have low levels of knowledge about hereditary breast cancer
mutations and low levels of medical mistrust.
Hypothesis 2: There will be a positive relationship between participants’ attitudes towards direct
to consumer testing and intentions to participate in PWT.
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Hypothesis 3: There will be a positive relationship between participants’ subjective norms and
intentions to participate in PWT.
Hypothesis 4: There will be a negative relationship between participants’ individual medical
mistrust and intentions to participate in PWT.
Hypothesis 5: There will be a negative relationship between participants’ group-based medical
mistrust and intentions to participate in PWT.
Hypothesis 6: There will be a positive relationship between participants’ perspectives towards
hereditary breast cancer mutations and intentions to participate in PWT.
Hypothesis 7: There will be a positive relationship between their perceived risk of hereditary
breast cancer mutations and intentions to participate in PWT.
Hypothesis 8: There will be a negative relationship between participants’ perceived severity of
breast cancer and intentions to participate in potential population-wide testing.

Methods
Survey Development
An online survey was administered to assess the factors that influence young African
American women’s intention to participate in PWT as a part of a larger sequential exploratory
mixed methods study. This survey was developed based upon the results of seven focus groups
with young African American women (n=39) in a southern urban city that focused on
perspectives of hereditary breast cancer mutations and motivators and barriers to participating in
PWT. Knowing that most participants may not know about PWT for hereditary breast cancer
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mutations, high level definitions of commonly used terms such as DTC testing, genetic
counseling, genetic testing, and PWT were included throughout the survey. An expert panel
consisting of four academic scholars each with experience in survey development, hereditary
breast cancer mutations, and breast cancer reviewed the survey developed by the first author. In
an effort to increase survey validity, the first author conducted two rounds of cognitive
interviews using the verbal probing method to test and obtain feedback from members of the
target population (Peterson, Peterson, & Powell, 2017). All discrepancies in the survey were
resolved by two coders at the end of the second round of cognitive interviews.
Sample and setting
Surveys were distributed and administered in July 2020 by the online survey company,
Qualtrics, to individuals in their existing online panels. Qualtrics randomly selected potential
survey participants based on the demographic information in the profiles of users that were most
likely to qualify for participation. Potential participants were sent an invitation to participate via
email that informed them of the survey, survey length, incentives for participation, and the
survey hyperlink. Potential participants who did not meet the established eligibility criteria were
excluded from participation. Participant inclusion criteria included women who: 1) selfidentified as African American or Black, 2) were between the ages of 18 and 30, and 3) did not
have a known hereditary breast cancer mutation in their family. A power analysis was conducted
using G*Power to determine the sample size in which the analysis would have a small effect
(Cohen’s h=05). The power analysis indicated a sample of 160 would be sufficient. Quota
sampling was used to stratify participants by age to ensure an equal number in each of the age
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ranges, 18 to 24 and 25 to 30 (Brown, 2016; Feild, Pruchno, Bewley, Lemay, & Levinsky, 2006).
Survey respondents were required to answer all questions to avoid skipped or missed survey
responses. Participants were provided with various incentives for participation in the study that
were provided by Qualtrics. Due to the exempt nature of this study, all participants were
provided with an information sheet prior to the survey that outlined the purpose of the study,
voluntary nature of participation, and minimal risks associated with participation in the study.
This study was approved by the Institutional Review Board at Virginia Commonwealth
University (HM200015881).
Measures
Predictors
Breast Cancer Genetics Knowledge was assessed using a 11-item scale that measures
knowledge about hereditary breast cancer mutations of women at risk for hereditary breast
cancers (Erblich et al., 2005). All the items in the scale require true or false responses. This scale
assessed the cancer risk associated with being a hereditary breast cancer mutation carrier, the
prevalence of hereditary genes, familial patterns of hereditary breast cancer mutation inheritance,
and various risk management options available to hereditary breast cancer mutation carriers. An
overall score was created by summing the correct responses to the items. Higher scores indicated
greater hereditary breast cancer mutations knowledge (scores range 0 to 11).
Group-Based Medical Mistrust was assessed using a 12 item, 5-point Likert scale, that
asks the respondent to think about the relationship between individuals of their race and the
medical system (Cronbach’s alpha = .741) (Thompson, Valdimarsdottir, Winkel, Jandorf, &
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Redd, 2004). It contains items, such as “Doctors have the best interests of people of my
racial/ethnic group in mind” and “People of my racial/ethnic group cannot trust doctors and
health care workers.” Responses range from strongly disagree to strongly agree. An overall score
was created by summing item responses together with higher values indicating greater groupbased medical mistrust (range 0-60).
Individual medical mistrust was assessed using a 7-item yes or no response scale that
examined participants’ experiences with discrimination in the healthcare field (Bird & Bogart,
2001 ). The main question of this scale asks, “When getting health care, have you ever had the
following things happen to you because of your race or ethnicity?” Respondents are then asked
to respond yes or no to statements such as, “Been treated with less courtesy than other people”
and “Received poorer service than others.” An overall score was created by summing item
responses together with higher values indicating greater individual medical mistrust (scores
range from 0 to 7) (Cronbach’s alpha = .818).
Perceived Risk of Carrying a BRCA1/2 Mutation was assessed by adapting a previously
used Likert item, “How likely do you think it is that you carry a BRCA1/2 mutation (Sussner,
Jandorf, Thompson, & Valdimarsdottir, 2013)?” In this current study, the item asked, “How
likely do you think it is that you carry a hereditary breast cancer mutation?” This was adapted in
order to account for other hereditary breast cancer mutations that are not necessarily BRCA1/2
mutations. The possible responses to this Likert scale item ranged from not at all likely,
somewhat likely, likely, very likely, and extremely likely.
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Perceived Severity was assessed using a three item 5-point Likert scale that measures
women’s perceived severity of carrying a gene mutation. It contains the following three items:
1). “If I found out I carried a gene mutation, it would greatly disrupt my life,” 2) “Finding out I
carried a gene mutation would be very difficult for me,” and 3) If I found out I carried a gene
mutation, I would worry much more about developing breast cancer (Wang, Gonzalez, Janz,
Milliron, & Merajver, 2007).” The responses to these items range from strongly disagree to
strongly agree (Cronbach’s alpha = .787). An overall score was created by summing item
responses with higher scores indicating greater perceived severity (scores range from 0 to 15).
Attitudes towards hereditary breast cancer mutations were assessed using a 13-item, 5point Likert scale that measures women’s perceived advantages and disadvantages to undergoing
genetic counseling and testing for hereditary breast cancer mutations (Cronbach alpha=.662)
(Thompson et al., 2002). It contains items such as “Testing is not worthwhile because it could
yield inconclusive results about whether I carry the gene for breast cancer” and “If I were found
to carry the gene for breast cancer, I would worry about passing the gene to my children.” The
possible item responses ranged from strongly disagree to strongly agree. An overall score was
created by summing the correct responses together. Higher scores indicate greater perceived
advantages of hereditary breast cancer mutations (scores range from 0 to 65).
Subjective Norms were assessed by adapting a 5 item, 5-point Likert scale that asks
women to consider what close relatives and friends would think of them undergoing genetic
counseling and testing for BRCA 1/2. Example items include, “My parents would approve of me
getting genetic testing and counseling for BRCA 1/2” and “My friends would approve of me
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getting genetic testing and counseling for BRCA 1/2. Possible item responses range from strongly
disagree to strongly agree (Cronbach’s alpha = .864). In this current study, scale items were
reframed to focus on whether their friends, family, spouse, or other family member would
approve of them getting genetic testing and counseling through PWT. An overall score was
created by summing the items together. Higher scores indicate more positive subjective norms
(scores range from 0 to 25).
Attitudes towards Direct to Consumer Genetic Testing were assessed using two scales to
understand respondents’ perspectives towards direct to consumer genetic testing
(Mavroidopoulou, Xera, & Mollaki, 2015). The first 7-item, 5-point Likert scale explored
respondents’ motivations to participate in DTC testing (scores range from 0 to 35) (Cronbach’s
alpha = .829). An overall score was created by summing all the response items together. Higher
scores indicated greater agreement with the potential reasons to participate in DTC testing. The
second 4-item scale explored respondents’ reasons for not wanting to participate in direct to
consumer genetic testing (scores range from 0 to 20) (Cronbach’s alpha = .612). An overall score
was created by summing all of the response items. Higher scores indicated greater agreement
with the potential reasons not to participate in DTC testing. Responses for both direct to
consumer participation scales range from strongly disagree to strongly agree.
Demographic Characteristics.
The survey collected respondents’ age, race, income, level of education, family history of
breast cancer, marital status, health insurance status, employment status, and whether they had a
regular physician. For the analysis, family history of breast cancer was dummy coded as yes/no.
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Education level was categorized into three levels: 1) less than or equal to high school, 2) any
college to a Bachelor’s degree, and the referent category 3) graduate degree. Marital status was
categorized into four levels: 1) married, 2) living together, 3) divorced, and the referent category
4) never married.
Outcome
Intentions for potential population-wide testing for BRCA 1/2 scale was assessed by
adapting an item that has been validated by a prior study on intentions that asks “At the present
time, which of the following statements describes you best?” The possible responses to this
Likert scale item are: definitely will have genetic testing, probably will have genetic testing,
considering genetic testing, and not considering/thought about genetic testing (Lerman et al.,
1999). This item was adapted to ask, “Now try to imagine you are offered genetic testing and
counseling for breast cancer susceptibility through a population-wide testing initiative at some
point in the future, would you choose to have the test?” The possible responses to this Likert
item are: no definitely not, no probably not, unsure, yes probably, and yes definitely.

Statistical Methods
Descriptive statistics were run to describe the variables of interest in this study. Total
mean scores and standard deviations were computed for each of the continuous predictor
variables. The dependent variable, intention, was assessed for normality. Unadjusted simple
regressions were conducted to assess the relationship between each of the predictor variables (i.e.
group-based medical mistrust, individual medical mistrust, perceived risk, perceived severity,
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attitudes towards hereditary breast cancer mutations, subjective norms, and attitudes towards
direct to consumer testing) and intentions to participate in population-wide testing. All
assumptions were assessed and met for each of the unadjusted analyses. Variables were selected
for separate adjusted multiple regression analyses based upon their significance in the initial
unadjusted analyses. Each adjusted analysis accounted for potentially confounding variables,
including family history, marital status, and level of education based upon findings from the
initial focus groups. Multicollinearity was assessed for each of the adjusted analyses by
conducting bivariate correlations. All analyses were conducted using SPSS 25.0.
Results
Among the individuals recruited for participation in the survey by Qualtrics, 391
individuals opened the survey link and were presented the IRB approved information sheet. Of
the 391 individuals who opened the link, 113 were ineligible to participate based upon the
study’s inclusion criteria and an additional nine participants were over-sampled. Another 99
failed to complete the survey. A total of 170 African American women between the ages of 18
and 30 are included in the study sample.
Most participants attended some college (62.3%), were employed either full-time or parttime (60.6%), never married (61.8%) and had an income less than $40,000 (55.3%). Further,
most of the women in the study had a regular physician (65.3%), health insurance (68.2%), and
did not have a family history of breast cancer (81.2%). The scores on the knowledge of
hereditary breast cancer mutations scale ranged from 2 to 10 with a mean score of 6.1 (standard
deviation = 1.53). The individual medical mistrust scale total range of scores were from 0 to 7
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with a mean score of 6.6 (standard deviation = 2.33). The group medical mistrust scale total
range of scores were from 12 to 58 with a mean score of 35.9 (standard deviation = 6.51) (Table
1).
Table 1: Frequencies of Demographic Variables and Predictor Scale means

Variables

N (%)

Mean (SD)

Demographic Variables
Age

23.7 (4.00)

18-24 years
25-30 years
Marital Status

85 (50%)
85 (50%)

Married

20 (11.8%)

Never married

105 (61.8%)

Living together
Divorced

28 (16.5%)
17 (10.0%

Education level
Less than or equal to high school

64 (37.6%)

Any College to a Bachelor’s Degree

92 (54.1%)

Graduate Degree

14 (8.2%)

Insurance Status
Yes
No

116 (68.2%)
54 (31.7%)

Income
Less than $20,000

53 (31.2%)

$20,000 -$39,999

41 (24.1%)
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$40,000-$59,999

38 (22.4%)

$60,000- $79,999

13 (7.6%)

$80,000-$99,999

10 (5.9%)

$100,000- $119,999

7 (4.1%)

At least $120,000

8 (4.7%)

Employment Status
Full time

69 (40.6%)

Part-time

34 (20.0%)

Unemployed

24 (14.1%)

Retired

4 (2.4%)

Unable to work

6 (3.5%)

Homemaker

11 (6.5%)

Student
Family History of Breast Cancer

22 (12.9%)

Yes

32 (18.8%)

No
Regular Physician
Yes
No

138 (81.2%)
111 (65.3%)
59 (34.7%)

Predictor Variables
Attitudes towards BRCA1/2
Subjective Norms
Individual Medical Mistrust
Group-based Medical Mistrust
Perceived Severity

42.0 (6.7)
16.3 (4.4)
6.6 (2.3)
35.9 (6.5)
9.7 (2.9)
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Perceived Risk
DTC Motivations
DTC barriers

2.1 (1.9)
24.9 (5.7)
11.5 (3.1)

The dependent variable, intention, was not normally distributed as indicated by the
Shapiro-Wilks test with a p-value of .000. The majority of the responses to the intention to
participate in PWT was “Unsure” (n = 75). There were not any statistically significant
relationships between intention to participate in PWT and the simple regression models with
group medical mistrust (B = -.075, 95% CI : [-.037, .012], p=.332), individual medical mistrust
(B = .140, 95% CI: [-.005, .132], p = .070), reasons to not participate in direct to consumer
testing scale (B = -.060, 95% CI: [-.073, .031], p=.436), perceived risk for hereditary breast
cancer mutations (B =.066, 95% CI: [-.076, .194], p = .391), perceived severity (B = .124, 95%
CI: [-.010,.101],p =.106), or attitudes towards hereditary breast cancer mutations (B = .070, 95%
CI: [-.014, .038],p = .362) (Table 2). Subjective norms were positively associated with intentions
to participate in PWT for hereditary breast cancer mutations (B =.460, 95% CI: [.077, .142], p <
.000). Subjective norms accounted for 20.7% of the variation in respondents’ intentions to
participate in PWT (F (1,168) = 44.99, p = .000). The relationship between subjective norms and
intentions to participate in PWT remained statistically significant in the multiple regression
model that accounted for family history of breast cancer, marital status, and level of education (B
= .449, 95% CI: [.074, .141], p = .000). The overall adjusted model remained significant (F, (7,
162) = 6.60, p < .000). Motivations to participate in direct to consumer testing was also
positively associated with intentions to participate in PWT for hereditary breast cancer mutations
73

in the simple linear regression (B = .217, 95% CI: [.013, .067], p = .004). Motivations to
participate in direct to consumer testing accounted for 4.2% of the variation of respondents’
intentions to participate in PWT (F (1,168) = 8.32, p = .004). Despite the overall model not
remaining significant (F (7,162) = 1.71, p = .110), the relationship between motivations to
participate in direct to consumer and intentions to participate in PWT also remained statistically
significant in the multiple regression model that accounted for family history of breast cancer,
marital status, and level of education (B = .204, 95% CI: [.010, .066], p =.009).

Table 2: Simple Linear Regressions with each of the Predictor Variables and Intentions for
potential population-wide testing

Dependent Variable
Intention to participate in population-wide testing
Standardized beta (pvalue)

95% CI

Adjusted R2

.012

.070 (p = .362)

(-.014, .038)

-.001

- .012

-.075 (p = .332)

(-.037,.012)

.000

Individual medical mistrust

.063

.140 (p = .070)

(-.005, .132)

.014

DTC Motivations

.040

.217 (p = .004) *

(.013, .067)

.042

Predictor Variables
Attitudes towards BRCA
Group-based medical mistrust

Unstandardized beta

DTC Barriers

- .021

- .060 (p = .436)

(-.073, .031)

-.002

Perceived Risk

.059

.066 (p = .391)

(-.076, .194)

-.002
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Perceived Severity

.046

.124 (p = .106)

(-.010, .101)

.010

Subjective Norms

.110

.460 (p = .000) *

(.077, .142)

.460

*p < .05
Table 3: Multiple Regression models adjusting for marital status, level of education, and family
history of breast cancer
Model 1

Beta

95% CI

Constant

.923
.449*

(.178, 1.667)
(.074,.141)

Subjectiv
e Norms
Marital
Status
Married

.063

Pvalue
.015
.000*

(-.267,.680)

.390

Model 2
Constant
DTC
Motivation
s
Marital
status
Married

Beta

95% CI

P-value

1.68

(.789, 2.569)

.000

.204*

(.010, .066)

.009*

.102

(-.185, .848)

.207

Living
together

.003

(-.394, .409)

.970

Living
Together

.027

(-.361, .516)

.728

Divorced

-.002

(-.506,.490)

.975

Divorced

-.031

(-.654, .439)

.698

.139

(-.325, .927)

.344

.173

(-.238, .969)

.233

Never
Married a
Educatio
n Status
Less than
or equal
to HS
Any
College
to a
Bachelor’
s
Graduate
degree a

.143

.145

(-.261, .882)

(-.246,.857)

.285

.275

Never
Married a
Education
Status
Less than
or equal to
HS
Any
College to
a
Bachelor’s
Graduate
degreea

75

Family
history of
breast
cancer

.044

(-.254, .493)

.528

Family
history of
breast
cancer

.065

(-.238, .969)

.396

*p<.05
a
Referent Group (coded 0)
Discussion
This is the first known study aiming to understand the factors that influence young
African American women’s (ages 18-30) intentions to participate in population-wide testing for
hereditary breast cancer mutations. Preemptively understanding the factors that influence young
African American women’s intentions to participate in PWT for hereditary breast cancer
mutations is imperative given the existing breast cancer and genetic counseling and testing
utilization disparities that exist in this population. Recent studies provide strong support for PWT
to become a reality in the future (Manchanda & Gaba, 2018; Manchanda, Legood, et al., 2015;
Rubinsak et al., 2019) citing cost-effectiveness, benefits for breast cancer prevention, and
acceptability of this initiative. This study assessed African American women’s current
knowledge of hereditary breast cancer mutations and their levels of medical mistrust. It also
examined potential factors, such as attitudes and environment constraints, that could be
associated with intentions to participate in PWT for hereditary breast cancer mutations if, and
when, offered in the future.
Study participants indicated a moderate level of knowledge about hereditary breast
cancer. The moderate knowledge of hereditary breast cancer mutations finding is particularly
important given that knowledge has been found to be a significant predictor of genetic
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counseling and testing uptake for hereditary breast cancer mutations amongst African American
women (Hurtado-de-Mendoza et al., 2017). These findings are similar to a prior study with
African American breast cancer survivors at risk for carrying a hereditary breast cancer mutation
that have found that younger age was a significant predictor of having a higher knowledge of
hereditary breast cancer mutations (Hurtado-de-Mendoza et al., 2017). Moderate knowledge
levels amongst younger African American women could potentially be due to recent mainstream
conversations about hereditary breast cancer mutations in the media (Leach, 2019). Discussions
about hereditary breast cancer mutations have been included in popular television shows
targeting young adults. In 2018, a popular show on ABC Freeform channel that targets young
adults, The Bold Type, presented a storyline of a young 26-year-old woman getting tested and
finding out that she had a hereditary breast cancer mutation and how being a mutation carrier
impacted every aspect of her life throughout the season (Leach, 2019). Therefore, younger
African American women may have been exposed to more information about hereditary breast
cancer than older African American women who participated in past studies.
Subjective norms were positively associated with young African American women’s
intentions to participate in any future PWT. Our findings differ from a prior study exploring
factors that impact young African American breast cancer survivors’ with a slightly larger age
range (ages 20-45) that found their uptake of genetic counseling and testing was not influenced
by subjective norms (Jones et al., 2016). Differences between this current study may be due to
the fact that participants in the prior study were diagnosed between the ages of 20-45 but
participated in this study years later. Findings from this current study are consistent with studies
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that have focused on the introduction of new preventive health behaviors to young adult women,
such as HPV vaccination. Previous studies have consistently indicated that subjective norms are
positive predictors of young adult women’s intentions to get an HPV vaccination (Allen et al.,
2009; Gerend & Shepherd, 2012). Study findings suggest that, if PWT is implemented, familybased and social network behavioral interventions will likely need to be conducted prioritizing
young African American women as well as members of their social network. Family members
can serve both as deterrents and motivators to African American women’s participation in
genetic counseling and testing for hereditary breast cancer mutations (Sheppard et al., 2014);
therefore, social network intervention strategies are well-suited for this population given the
potential diverse opinions of family members. Similarly, public health campaigns targeting
young African American women will also need to reference social networks given the influence
of families and friends. Lastly, though not examined in this study, it may also be important for
future research to examine who exactly counts as social network members especially given the
pervasiveness of social media engagement and social media influencer culture including the
phenomenon of Facebook and Twitter friends and followers.
This is the first study to examine the relationship between young African American
women’s motivations to participate in DTC testing and intentions to participate in PWT for
hereditary breast cancer mutations. Our findings suggest that young African American women
may be more open to direct to consumer testing and may in turn influence their perspectives
towards PWT. This could potentially be attributed to the rise of marketing of direct to consumer
testing to consumers that began with Myriad Genetics in 2006 (Matloff & Caplan, 2008). Direct
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to consumer testing marketing has become increasingly popular with companies such as,
23andMe and Ancestry.com, that advertise their services on all platforms (Estrada, 2017). Direct
to consumer testing companies have not always effectively targeted African Americans in
advertisements. Ancestry.com recently had to pull a controversial tv commercial, entitled
“Inseparable”, after being accused of romanticizing the rape of an enslaved African American
woman by her White slave owner (Kearns, 2019). Despite this missed opportunity to target
African Americans, studies have consistently indicated that African Americans utilize DTC
testing at similar to rates as Whites (Carroll et al., 2019; Landry et al., 2017). Future research
should explore the linkages between young African American women’s intentions to participate
in PWT and their current participation in already widely available genetic testing services
offered through direct to consumer testing.
Medical mistrust is a known predictor of African American breast cancer survivors’
participation in genetic counseling and testing for hereditary breast cancer mutations (Sheppard
et al., 2014; Sheppard et al., 2013; Sutton et al., 2019). Consistent with prior studies, young
African American women in this study had moderate to high levels of medical mistrust.
However, despite having moderate to high levels of medical mistrust, neither individual or
group-based medical mistrust were associated with young African American women’s intentions
to participate in PWT. This finding suggests that while participants may distrust the medical
field, distrust may not negatively influence their health behaviors in the same ways as it has
traditionally among older African American breast cancer survivors. Future research should
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examine the impact of medical mistrust on young African American women’s intentions to
participate in PWT and subsequent uptake of PWT.
Other factors that have been typically found to be associated with intentions and uptake
of genetic counseling and testing for hereditary breast cancer mutations in prior studies with
breast cancer survivors both young and old were not significant in this current study (Jones,
McCarthy, Kim, & Armstrong, 2017; Kessler et al., 2005; Wang et al., 2007). Different from
prior studies with African American women at-high risk for hereditary breast cancer mutations,
perceived risk and attitudes towards hereditary breast cancer mutations were not significant
predictors of intention for young African American women that participated in this current study
(Jones et al., 2017; Kessler et al., 2005). These findings suggest that there are potentially other
important factors that were not included in this present study, such as cost, accessibility, and
confidence in the accuracy of testing. Future research should explore other factors and how they
can be best targeted and incorporated in behavioral interventions and public health campaigns.
Limitations
One limitation of this current study is that this was a highly educated sample with 62
percent of the sample having at least attended some college. Therefore, these findings may not be
reflective of the experiences of individuals who have not attended college. Another limitation is
that the survey sample is limited to individuals who are signed up to participate in online surveys
distributed by Qualtrics. As a result, findings may not represent the experiences of young African
American women in the general population or those with limited access to the internet. Future
research should include non-college attending young African American women as well as young
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African American women in the general population to understand if the factors that influence
their intentions to participate in potential PWT are different from the women who participated in
this study. Another limitation of this study was that the dependent variable, intention to
participate in PWT, was not normally distributed. The majority of responses to the intentions to
participate in PWT item was unsure. The non-normal distribution of the dependent variable may
impact the significance of the findings from this study given the potential impact of nonnormality on estimates of confidence intervals and standard errors in regression.
Conclusion
The potential for population-wide testing for hereditary breast cancer mutation could
serve as a pathway to breast cancer prevention for young African American women and reducing
existing breast cancer disparities. However, young African American women will not reap
preventive benefits of participation in a potential initiative if the factors that may influence their
intentions (attitudes and environmental constraints) are not understood prior to the
implementation of such a service. Without fully understanding these factors, the implementation
of such an initiative will only lead to the widening of existing disparities in the utilization of
genetic counseling and testing and subsequently increase disparities in breast cancer incidence
and mortality.
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Chapter 4
Introduction
There is a long-standing delay in the translation of academic research findings into public
health practice. Balas & Boren (2000) found that it takes 17 years on average for research
evidence to make its way into practice (Balas & Boren, 2000). Most public health researchers
and academics disseminate their findings primarily to academic journals. Journal publications
carry a significant weight for academic researchers while they are on the job market and during
the tenure and promotion process (Moore, Maddock, & Brownson, 2018). While worthwhile,
this siloed dissemination strategy continues to contribute to significant lags in the sharing of
evidence-based public health knowledge to key non-academic stakeholders, which includes
public health practitioners, policy makers, and the community at large. Without academic
researchers putting forth substantial efforts to utilize alternative dissemination strategies, public
health research findings will continue to have challenges reaching non-academic audiences.
Recent research has found that academic researchers are making efforts to close the translation
gap. For example, a recent survey has indicated that approximately 58 percent of public health
researchers associated with either federal agencies or universities disseminated their findings to
local state health departments in the U.S (McVay, Stamatakis, Jacobs, Tabak, & Brownson,
2016).
Non-academic stakeholders experience barriers to both accessing and understanding
research findings presented in peer-reviewed journals (Brownson, Eyler, Harris, Moore, &
Tabak, 2018). Public health practitioners at local, state, and federal health departments
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specifically lack access to journal articles, time, resources, and have the potential for information
overload (Brownson et al., 2018). In turn, this leads to missed opportunities to use these findings
to design evidence-based public health promotion programming and research, implement public
health policies, as well as promote health behaviors to the general public.
Efforts to close the translation gap between academic researchers and non-academic
audiences have taken different forms. More recently, academic researchers have disseminated
public health research findings to the general public using more accessible formats including
social media posts and websites, photovoice, and the creation of data briefs. (Brownson et al.,
2018). Data brief reports, in particular, provide the opportunity for the researcher to disseminate
research findings in an abbreviated format that also utilizes graphs and tables to illustrate study
findings (Brownson et al., 2018). For example, the Center for Disease Control and Prevention
has utilized data brief reports to disseminate findings from current public health topics ranging
from suicide rates to racial and ethnic disparities in infant mortality rates ("NCHS Data Briefs ",
2018). Briefs are created with the intent of targeting a specific population which can range from
the general public to public health practitioners (Brownson et al., 2018). This current paper
introduces a data brief entitled, “Population-wide testing for Hereditary Breast Cancer Genes:
Recommendations for Public Health Practitioners to Reach and Raise Awareness Amongst
Young African American women.” The target audience of this data brief are public health
practitioners working in local or state health departments with disproportionate breast cancer
burden amongst African American women. Public health practitioners working in these settings
are particularly important because they are tasked with creating health promotion programming
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and campaigns, connecting community members with health services, creating community
partnerships, and ensuring that the health workforce is skilled and competent (Stover & Bassett,
2003). Furthermore, these public health practitioners are responsible for operationalizing
academic research findings into practice (Stover & Bassett, 2003). Therefore, if PWT is
implemented in the future, public health practitioners serving in local and state health
departments in states with breast cancer disparities impacting African American women will
need to have concisely presented recommendations to reach and raise awareness around PWT in
this group. African American women in Virginia, specifically, are diagnosed at higher rates,
more advanced breast cancer stages, and are more likely to die from breast cancer than White
women (Health, 2016 ). Due to these existing breast cancer disparities in Virginia, this data brief
will be provided to stakeholders in both the Office of Health Equity and the Cancer Division at
the Virginia Department of Health. Furthermore, this data brief will be disseminated on the
Black Ladies In Public Health Facebook group that consists of over 10,000 African American
women who are public health practitioners in various organizations and health departments
across the country.
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P O P U L A T I O N - WIDE
TESTING FOR
H E R E D I T A RY B R E A S T
C A N CE R G E N E S:
RECOMMENDATIONS FOR PUBLIC
HEALTH PRACTITIONERS TO
REACH AND RAISE AWARENESS
AMONGST YOUNG AFRICAN
WOMEN
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RECOMMENDATIONS FOR
RAISING AWARENESS
ABOUT POPULATIONWIDE TESTING AMONG
YOUNG AFRICAN
AMERICAN WOMEN
•

Develop health promotion programs
that include members of young
African American women’s social
networks such as events that focus on
mothers and daughters.

•

Create public health campaigns that
display mothers or friends providing
information about the new initiative
and speaking favorably of
participation in testing.

•

Use targeted social media platforms
to communicate health
communication messages to young
African American.

•

Partner with Black breast cancer
organizations.

•

Train healthcare workers to increase
their cultural competency and
improve patient-provider
communication with young African
American women patients.

Public health practitioners working at local and state health
departments are perfectly positioned to target and raise
awareness about population-wide testing for hereditary breast
cancer mutations. Currently, population-wide testing is a
prospective future initiative that is garnering a lot of attention.
The decreasing cost of genetic testing may make this a possible
reality in the near future. Therefore, it is imperative to
proactively provide public health practitioners with
recommendations for potential programming, training, and
public heath campaign strategies to reach young African
American women, a group that is disproportionately impacted
by breast cancer. Recommendations provided in this brief are
based upon a research study that used focus groups and surveys
with young African American women, ages 18-30 years, who
are approaching the proposed screening age for populationwide testing.

What is population-wide testing?
Population-wide testing would allow all women, regardless of
their personal or family history of breast cancer, to utilize
genetic counseling and testing services for hereditary breast
cancer mutations. This initiative is being proposed for all
women in the United States beginning at age 30 (King, LevyLahad, & Lahad, 2014; Pal et al., 2015). Currently, only
women with a certain family or personal history of breast
cancer can be recommended for genetic tests (NCCN, 2018).
However, this approach typically leads to women lacking an
understanding of their increased susceptibility for breast cancer
until they have already been diagnosed (Jones et al., 2016; King
et al., 2014). The goal of population-wide testing would be to
create a pathway to breast cancer prevention.

Why is targeting young African American
women important?
Breast cancer is the second leading cause of cancer death for all
women in the U.S (DeSantis et al., 2019). Young African
American women are most likely to die from breast cancer and to
be diagnosed with more aggressive forms of breast cancer
(DeSantis et al., 2019). Moreover, young African American
women breast cancer survivors have a high rate of hereditary
breast cancer mutations, which substantially increase a women’s
risk for breast cancer over her lifetime (Anders, Johnson, Litton,
Phillips, & Bleyer, 2009; Pal et al., 2015). However, African
American women utilize genetic counseling and testing for
hereditary breast cancer at lower rates than White women
(Armstrong, Micco, Carney, Stopfer, & Putt, 2005; Jones et al.,
2016). To address these disparities, it is critical that future
programming, trainings, and public health campaigns are
designed with young African American women in mind.
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What do young African American women currently know
about heredity breast cancer?

•

Young African American women have a limited to moderate knowledge of hereditary
breast cancer mutations.

"I haven't heard much of it, honestly. I just know that breast cancer can sometimes be
hereditary in your family and some family members take precautions with their children at
young ages to make sure that they don't go through that." – Focus Group Participant

•

•

Only 30 percent of participants knew that a woman with a sister with the gene did
not have only a 1 in 4 chance of having the mutation herself.

•

50 percent of participants knew that women who test positive for breast cancer
gene mutations are more likely to develop breast cancer at an early age.

•

Nearly 69 percent of survey participants knew that 50 percent of inherited genetic
information is passed down from a person’s mother.

Young African American women are aware that women in their racial/ethnic group
have a heightened risk for more aggressive forms of breast cancer.

"And so, I do know that black, well this might be incorrect, but black
women can get some of the most aggressive forms of breast cancer." –
Focus Group Participant
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What are young African American women’s preferences for
information sources about population-wide testing?

Who: Young African American women want to receive information about
population-wide testing from their mothers, breast cancer survivors, and other
people that they trust including friends, relatives, and co-workers. They also
want to hear from health care professionals, including OBGYNs, primary care
providers, and nurses.

“I mean, my mom has a lot more knowledge than I do
because she actually had to go through and experience, she
actually had to get a mastectomy. So, I feel like I would go to her
first because she knows." - Focus Group Participant

How: Social media platforms including, Instagram, Facebook, and Twitter would
all be important information sources about population-wide testing.

"Social media, for sure. I mean, it's a huge platform already; use
it to your benefit. I think that social media probably takes up the majority
of most people's time, so definitely social media and using that as a
mechanism to communicate not only the importance of it, but the
accessibility of it and how to get it done."- Focus Group Participant
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Recommendations for Programming and Public Health
Campaigns for Population-wide Testing
Public health practitioners working at local and state health departments are in a
unique position to develop and implement health promotion programming,
clinician trainings, and public health campaigns, and to partner with community
organizations in their area to promote awareness about this potential initiative.

Programming for Young African American Women
•

Create programming that includes not only young African American
women, but also their mothers, other relatives, and peers. Providing
educational programming for multiple members of their social networks
could help to encourage additional conversations with these trusted
information sources.

•

Seek out partnerships with local African American breast cancer organizations when
creating programs for this initiative. African American breast cancer survivors could help
bring additional legitimacy through their sharing of personal breast cancer experiences to the
severity of breast cancer amongst Black women.

Training for Healthcare Providers
•

•

Create trainings for healthcare providers that raise awareness about hereditary breast cancer
mutations and their impact on racial minorities. Highlight the disparities in knowledge gaps
around hereditary breast cancer mutations and tendencies to refer African American women for
testing at lower rates than White women.
Increase cultural competency and patient-provider communication to address medical
mistrust and facilitate provider conversations with young African American women.

Public Health Campaigns
•

Develop health communication campaigns with scenarios displaying mothers or
friends providing information about the potential new initiative and speaking
favorably of participation in the service.

•

Disseminate information about population-wide testing on popular social media platforms.
Partner with well-known African American influencers, who young African American women
follow to provide them with information about population-wide testing.
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Data Sources and Methods
Recommendations presented in this brief report are based on focus group and surveys with 209
young African American women between the ages of 18 and 30. Seven focus groups were
conducted with 39 African American women who were either enrolled at one of two local
colleges, Virginia Commonwealth University and Virginia Union University, or who were
community residents in the Greater Richmond area. The majority were unmarried (94.9%),
employed full-time (76.9%), were enrolled in college (64%), and did not have a family history
of breast cancer (53.8%). Findings from this focus group were used to create a survey that was
distributed to a larger online sample via Qualtrics Online Sample (n=170). Results from this
study may not represent young African American women who do not participate in Qualtrics
panels and more specifically, young women who have limited access to the internet.
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Chapter 5
Discussion
Population-wide testing (PWT) could be a significant pathway to breast cancer
prevention for young African American women. Preemptively exploring their perspectives
towards PWT is an important first step towards ensuring that existing breast cancer and genetic
testing utilization disparities are reduced if PWT is implemented in the future. Therefore, the
purpose of this dissertation was to conduct a sequential exploratory mixed methods study to
preemptively understand young African American women’s (ages 18-30) perspectives and
contributing factors towards hereditary breast cancer mutations and intended use of PWT if it
were to be implemented in the future. The two main aims guiding this study were: 1) identify
young African American women’s knowledge gaps and attitudes towards genetic counseling and
testing as well as direct to consumer testing (DTC); assess motivators and barriers to
participating in PWT and determine health communication preferences for PWT for hereditary
breast cancer mutations; and 2) examine the factors that influence young African American
women’s intentions to participate in PWT for hereditary breast cancer mutations.
Study findings were presented in the form of two manuscripts intended for peer review
and a data brief aimed at public health practitioners at local and state health departments in urban
cities with disproportionate breast cancer burden amongst African American women. The first
paper presented findings from the focus groups conducted as a part of Aim 1 by examining
young African American women’s perspectives towards PWT. The second paper presented the
survey findings and explored factors that influence intentions to participate in PWT for
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hereditary breast cancer mutations. This study had eight main hypotheses that explored the
influence of multiple factors (i.e. attitudes towards DTC, subjective norms, group-based medical
mistrust, individual medical mistrust, perceived risk, perceived severity, and perspectives
towards hereditary breast cancer mutation) on intentions to participate in PWT. The third paper
was presented in the format of a data brief and included health communication-related findings
from both Aims 1 and 2. Specifically, the brief presented recommendations for public health
practitioners working at local and state health departments to best reach and raise awareness
amongst young African American women about the new initiative. Taken together, this
formative study provides insight into existing knowledge gaps and attitudes that can inform
future public health campaigns, behavioral interventions, clinician trainings, and breast cancer
prevention programming with young African American women.
Knowledge about hereditary breast cancer mutations varied between the focus groups and
surveys. While the majority of focus group participants expressed having limited to no
knowledge about hereditary breast cancer mutations, survey respondents indicated moderate
knowledge. Survey findings are consistent with a prior study which found that younger age was a
significant predictor of greater knowledge about hereditary breast cancer mutations amongst
African American breast cancer survivors at high risk for the mutations (Hurtado-de-Mendoza,
Jackson, Anderson, & Sheppard, 2017). Differences in study findings could be due to the openended way in which the question was asked in the focus group setting versus the true/false
knowledge scale that was used in the survey. Another potential explanation is that the survey
captured a larger sample, therefore ultimately providing insights about the knowledge level of a
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larger sample. Knowledge is a particularly important indicator in that it has been found to predict
genetic counseling and testing utilization amongst African American women (Hurtado-deMendoza et al., 2017). Therefore, this current study suggesting that participants have limited to
moderate knowledge about hereditary breast cancer mutations may indicate the need for more
specific education in this group.
Medical mistrust was a common thread in the focus groups and survey data. Overall,
participants indicated that they had moderate to high levels of medical mistrust. In the focus
groups, medical mistrust was a commonly cited disadvantage and barrier to participation in DTC
testing, the current model of genetic counseling and testing, as well as PWT. Consistent with
prior research (Adams, Christopher, Williams, & Sheppard, 2015; Sheppard et al., 2014;
Sheppard, Mays, Tercyak, & LaVeist, 2013), participants were keenly aware of the differences in
quality of care, potential exploitation by the medical field, as well as had concerns about the
confidentiality of testing results. When asked specifically about PWT, participants indicated that
more research would be needed for them to be comfortable with participating in PWT. High
levels of medical mistrust might be attributed to mainstream conversations about Black maternal
mortality, for example, in 2018, the near death experience during childbirth by top tennis player,
Serena Williams due to her doctor not listening to her concerns (Haskell, 2018). Despite study
participants high levels of medical mistrust, this variable was not associated with intentions to
participate in PWT. This finding is particularly important given that medical mistrust has
consistently been found to be a significant barrier to utilization of genetic counseling and testing
amongst African American women at high risk for being a mutation carrier (Sheppard et al.,
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2013). Findings from this current study suggest that even though participants may have high
levels of medical mistrust, it may not have the same impact on their intentions to participate in
PWT.
Cost was another commonly cited barrier to participation in all three genetic testing
services explored in the focus groups. Cost has been consistently cited as a common barrier to
African American women’s participation in traditional genetic testing (Adams et al., 2015;
Sheppard et al., 2014). In this study, participants were not only concerned about the affordability
of testing for themselves but were also more broadly hyperaware of potential disparities in access
to testing for underrepresented minorities and socio-economically disadvantaged groups.
Focus group participants indicated several benefits and motivators to participating in
DTC testing, the current model of genetic testing, and PWT. Similar to prior studies that explore
African American’s perspectives towards DTC testing (Carroll et al., 2019; Landry et al., 2017),
participants indicated that DTC testing was beneficial for learning more about ancestry and
about personal risk for disease. Perhaps indicating the proliferation of direct to consumer testing,
among survey participants, motivations to participate in direct to consumer testing was
associated with intentions to participate in PWT. Similar to other research, advantages of the
current model of genetic testing in a prior study (Adams et al., 2015), such as early detection,
being informed, and the opportunity to make lifestyle changes, were also expressed by focus
group participants. There was no association between participants’ attitudes towards hereditary
breast cancer mutations and intentions to participate in PWT, despite perceived benefits of
genetic counseling and testing being a predictor of genetic counseling and testing utilization in a
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prior study with older African American women at high risk for a hereditary breast cancer
mutation (Jones, McCarthy, Kim, & Armstrong, 2017). When focus group participants were
asked about potential motivators to participate in PWT, they cited common motivators such as
having children and a family history of breast cancer that may put them at high risk (Adams et
al., 2015). Furthermore, given the distrust of the medical field, participants noted the importance
of access to quality healthcare as a motivator to participate in the potential new initiative.
In the survey, we explored the impact of subjective norms, perceived severity, and
perceived risk on intentions to participate in PWT. Different from a prior study found that
subjective norms did not influence genetic testing amongst African American women who had
been diagnosed with breast cancer at a young age (Jones et al., 2016), this current study found
that subjective norms was a significant predictor of intentions to participate in PWT. Differences
between this current study may be due to the fact that participants in the prior study were
diagnosed between the ages of 20-45 but participated in this study years later. Findings from this
current study suggest that young African American women would be influenced by members of
their social network including, family and friends, to participate in PWT. Neither perceived risk
for breast cancer nor perceived severity was associated with intentions among survey
participants.
Strengths, Limitations and Future Directions
This current study addresses a significant gap in the existing literature by exploring
young African American women’s (18-30 years) perspectives about PWT and contributing
factors that influence their intentions to participate in PWT. A strength of this study is that it
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explores the perspectives of those who would be approaching the proposed screening age for
PWT if it is implemented in the future. The majority of existing studies have focused solely on
those African American women who have a family or personal history suggestive of a hereditary
breast cancer mutation (Hurtado-de-Mendoza et al., 2017; Jones et al., 2016; Sheppard et al.,
2014; Sutton et al., 2019). There are limited studies on attitudes towards PWT (Rubinsak et al.,
2019) and currently no studies that specifically focus on young African American women.
Another strength of this study is that it used a sequential exploratory mixed methods study
approach starting with qualitative research which allowed for an in-depth exploration of potential
factors that were salient for this specific population and were then included in the larger survey.
Lastly, the use of cognitive interviews was another strength of this current study given that they
helped to increase the validity of the survey instrument prior to distribution.
However, there are a various limitations. Overall, this study may also not be
representative of non-college attending and low income young African American women who
may experience additional barriers, such as competing priorities and lack of employment-based
health insurance, that may impact intentions to participate in PWT for hereditary breast cancer
mutations. Another limitation of this study was that the dependent variable, intention to
participate in PWT, was not normally distributed. The majority of women indicated that they
were unsure about their intentions to participate in PWT. Future studies should be conducted
with low income and non-college attending young African American women to explore whether
their knowledge of hereditary breast cancer mutations, attitudes, and motivators and barriers to
participating in PWT differ from the study participants.
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There are several other potential research directions that could stem from this research.
Family and peer interventions could be beneficial in this group given the influence they have on
participants intentions to participate in PWT. Furthermore, health communication related
findings from this study suggest that interventions on social media platforms, such as Twitter and
Instagram, may be well-suited for this group. Additional research should also determine what
other factors may influence intentions to participate in PWT. Other factors that may be important
for this group include, genetic counseling and the testing experience, preference for the type of
medical professional providing the testing, and accessibility of testing, all of which may impact
intentions to participate in PWT. Future research should focus on testing interventions with
clinicians including primary care physicians and gynecologists, to not only raise knowledge
about hereditary breast cancer mutations but also to improve their health directed messaging with
young African American women. It will also be important for future research efforts to prioritize
African American women who are older than 30 who may also be able to utilize PWT as a
pathway to breast cancer prevention given that African American women shoulder a
disproportionate burden of breast cancer mortality at every age (DeSantis et al., 2019). Lastly,
African American women’s perspectives of PWT as it relates to ovarian cancer should be
explored given that hereditary breast cancer mutations also substantially heighten a woman’s risk
for ovarian cancer over her lifetime (Srivastava et al., 2017). Moreover, similar to existing breast
cancer disparities, African American women tend to be diagnosed with ovarian cancer at more
advanced stages and have higher mortality rates than White women (Srivastava et al., 2017).
Implications for Practice
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There are several implications of this research for practice that can be implemented by
public health practitioners. First, is the use of social media as a strategy to develop targeted
public health campaigns about PWT. Social media has become an integral part of the everyday
lives of many individuals and is increasing becoming a significant source of health-related
information (Li, Wang, Lin, & Hajli, 2018; Zhou, Zhang, Yang, & Wang, 2018). For example,
the social media platform, Instagram, is a prime source for disseminating public health
campaigns because users typically represent diverse socio-economic backgrounds and tend to be
younger (Perrin & Anderson, 2019). Black users worldwide represent a greater percentage of
Instagram users than Whites (Perrin & Anderson, 2019). Despite the potential utility of social
media platforms, prior studies have consistently found that public health organizations
underutilize socials media as a conduit of health communication (Basch & MacLean, 2019;
Miller, Guidry, & Fuemmeler, 2019). Second, potential health promotion strategies might
include partnerships with influencers on both Twitter and Instagram. Partnerships with popular
influencers that have a large following on social media may provide an entryway for public
health messages about such an initiative using popular hashtags, such as #BlackTwitter that have
the potential to quickly circulate information to members of the African American community.
Public health campaigns on both social media and traditional platforms will need to not only
target young African American women but also members of their social network and will need to
emphasize the importance of key members of their social network, such as parents and friends.
This study also has implications for public health programming. Similar to public health
campaigns, findings suggest that it may be beneficial to create programming that targets not only
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the young woman but also key social network members. One example of potential programming
could be a mother- daughter event that increases awareness amongst the dyad about PWT. The
goal of this type of programming would be to spark additional conversations after the event
about the importance of PWT. Study findings suggest that it may be important to partner with
Black breast cancer organizations to create programming. These organizations are regarded as
highly credible and their support may enhance the importance of breast cancer prevention efforts,
such as PWT, amongst young African American women.
Findings also suggest that it may be important to develop trainings for healthcare
providers in an effort to help promote the participation of young African American women
patients in PWT. Given that healthcare professionals lack knowledge about hereditary breast
cancer mutations (Christensen et al., 2016; Hauser, Obeng, Fei, Ramos, & Horowitz, 2018), it
may be important to develop trainings to increase knowledge about hereditary breast cancer
mutations and PWT among these professionals. Furthermore, additional training focusing on
both cultural competency and patient-provider communication could be beneficial to assuaging
medical mistrust amongst young African American women.
Conclusion
PWT for hereditary breast cancer mutations for all women beginning at age 30 has been
proposed as a viable potential pathway to breast cancer prevention for all women (King, LevyLahad, & Lahad, 2014). This was the first study to preemptively explore young African
American women’s perspectives and intentions to participate in PWT. Findings from this study
provide insights about young African American women’s current knowledge gaps about
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hereditary breast cancer mutations, potential motivators, and barriers to their participation in
PWT, and recommendations for future research and practice. Ultimately, if PWT is
implemented, preemptively prioritizing this group will be imperative to reducing existing breast
cancer disparities impacting young African American women.
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Appendix 1: Chapter 2
Recruitment Email
To whom it may concern,
My name is Alesha Henderson and I am a doctoral candidate in the Department of Health
Behavior and Policy at Virginia Commonwealth University. I am writing to invite you to
participate in a research study that focuses on young African American women’s perspectives of
hereditary breast cancer mutations and their health communication preferences. This study calls
for the participation of African American women between the ages of 18 and 30 from the Greater
Richmond Area.
Participation in this study involves:
•
•
•

Answering questions about hereditary breast cancer mutations and health communication
preferences
60-minute focus group in a private room on VCU’s campus or at a library in the Greater
Richmond Area
Compensation will be provided

If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the
Department of Health Behavior and Policy at Virginia Commonwealth University.

Social media recruitment
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Research study about Hereditary Breast Cancer Mutations and
Health Communication Preferences
Purpose: We want to examine young women’s perspectives about hereditary breast cancer
mutations and potential population-wide testing for hereditary breast cancer mutations.
We are looking for young African American women to participate in a focus group.
Who can participate?
•

African American women in the Greater Richmond Area between the ages of 18 and 30.

What does participation involve?
• Answering questions about hereditary breast cancer mutations and health communication
preferences
• 60-minute focus group in a private room on VCU’s campus or at a library in the Greater
Richmond Area
• Compensation will be provided
If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the
Department of Health Behavior and Policy at Virginia Commonwealth University.
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Eligibility Screening for Focus Groups
1.

Do you identify as Black or African American women?

2.

Are you between the ages of 18 and 30 years old?
a. If so, what is your age? _________
Do you live in the Greater Richmond Area?

3.

□ Yes
4.

□ No
□ No

□ No

a. If yes, what is your city and county of residence?
_____________________________________________________________
Do you have a known hereditary breast cancer mutation?

□ Yes
5.

□ Yes
□ Yes

□ No

Are you currently enrolled at Virginia Commonwealth University?

□ Yes
a.

□ No

If yes, what degree program are you pursuing?
___________________________________________________

6.

Are you currently enrolled at Virginia Union University?

□ Yes
a.

□ No

If yes, what degree program are you pursuing?
_____________________________________________________

RESEARCH PARTICIPANT INFORMATION SHEET
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TITLE: Changing Landscapes: Perspectives of Young African
American women of Population-Wide Testing for Hereditary Breast
Cancer Mutations
VCU IRB NO.: HM20015881
PRINCIPAL INVESTIGATOR:

Alesha Henderson, M.A.
Department of Health
Behavior & Policy Virginia
Commonwealth University
Phone: 804-614-8304
Email:
Hendersonan2@mymail.vcu.edu
Maghboeba Mosavel, PhD
Department of Health
Behavior & Policy Virginia
Commonwealth University
Richmond, Virginia 232980149
Phone: (804) 628-2929
Fax: (804) 828-5440

PURPOSE OF THE STUDY
You are being invited to participate in this research study about population-wide testing for
hereditary breast cancer mutations and your health communication preferences. The results of
this study will be used to develop a survey that will be distributed to a larger sample of young
African American women. In this study, you will be asked to visit a conveniently located room
at a library in the Greater Richmond Area or on Virginia Commonwealth University’s campus
to participate in a 60-minute focus group about hereditary breast cancer mutations and health
communication preferences.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation in this research study is voluntary. You do not have to participate in this
study. If you choose to participate, you may stop at any time without any penalty. You may also
choose not to answer particular questions that are asked in the study. Discontinuing your
participation or withdrawing from the study will not result in any loss or benefits to which you
are otherwise entitled. If you decide to join the study, you may withdraw at any time and for
any reason without penalty or loss of benefits.
113

RISKS AND DISCOMFORTS
There are minimal risks associated with participation in this study. Questions posed in the
focus groups should not cause any distress to you given that they are not personal in nature but
if they do, you can choose to skip any question that you do not feel comfortable with and can
discontinue your participation in this study at any time. There is also a risk of a loss of
confidentiality or privacy. Other members of the focus groups will be able to see that you are
in the study and hear your responses, but we will not share any other information you provide
to us with other members of the group.
PAYMENT FOR PARTICIPATION
As a display of our appreciation for your participation in this study, you will receive a $15
gift card when you complete the focus group.
QUESTIONS
If you have any questions, concerns, or complaints about this study now or in the future, please
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu.
She is currently a doctoral candidate in the Department of Health Behavior and Policy at
Virginia Commonwealth University.
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Appendix 2 Chapter 3

Research study about Hereditary Breast Cancer Mutations and
Health Communication Preferences
Purpose: We want to get young African American women’s feedback on a survey that will be
distributed to a larger sample of young African American women.
We are looking for young African American women to participate in an interview.
Who can participate?
•

African American women between the ages of 18 and 30 who are community residents in the Greater
Richmond Area.

AND
•

African American women between the ages of 18 and 30 that attend Virginia Commonwealth
University or Virginia Union University

What does participation involve?
•
•
•
•

Participating in a 60 minute telephone interview
Review an online survey on your cellphone or computer
Providing feedback on its’ design and questions
Incentives will be provided.

If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the
Department of Health Behavior and Policy at Virginia Commonwealth University.
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To whom it may concern,
My name is Alesha Henderson and I am a doctoral candidate in the Department of Health
Behavior and Policy at Virginia Commonwealth University. I am writing to invite you to
participate in a research study that focuses on young African American women’s perspectives
of hereditary breast cancer mutations and their health communication preferences. This study
calls for the participation of African American women between the ages of 18 and 30 from the
Greater Richmond Area. We are specifically looking for students enrolled at either Virginia
Commonwealth University or Virginia Union University. African American women between the
ages of 18 and 30 who are community residents in the Greater Richmond area are also eligible
to participate.
Participation in this study involves:
•
•
•

Participating in a 60 minute telephone interview ($10 gift card for participation)
Review an online survey on your cellphone or computer
Providing feedback on its’ design and questions

If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the
Department of Health Behavior and Policy at Virginia Commonwealth University.
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Eligibility Screening for Cognitive Interviews
1.

Do you identify as Black or African American women?

2.

Are you between the ages of 18 and 30 years old?
a. If so, what is your age? _________

3.

Do you live in the Greater Richmond Area?

□ Yes

□ Yes
□ Yes

□ No
□ No

□ No

a. If yes, what is your city and county of residence?
_____________________________________________________________
4.

Do hereditary breast cancer mutations run in your family?

□ Yes
5.

□ No

Are you currently enrolled at Virginia Commonwealth University?

□ Yes
a.

□ No

If yes, what degree program are you pursuing?

_________________________________________________________________________
6.

Are you currently enrolled at Virginia Union University?

□ Yes
a.

□ No

If yes, what degree program are you in?

7, Do you have access to the internet via either a cellphone or computer?

□ Yes

□ No
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RESEARCH PARTICIPANT INFORMATION SHEET FOR VERBAL CONSENT
TITLE: Changing Landscapes: Perspectives of Young African American women of PopulationWide Testing for Hereditary Breast Cancer Mutations
VCU IRB NO.: HM20015881
PRINCIPAL INVESTIGATOR:

Alesha Henderson, M.A.
Department of Health
Behavior & Policy Virginia
Commonwealth University
Phone: 804-614-8304
Email: Hendersonan2@mymail.vcu.edu
Maghboeba Mosavel, PhD
Department of Health
Behavior & Policy Virginia
Commonwealth University
Richmond, Virginia 232980149
Phone: (804) 628-2929
Fax: (804) 828-5440

PURPOSE OF THE STUDY
You are being invited to participate in this research study about population-wide testing for
hereditary breast cancer mutations and your health communication preferences. The results of
this study will be used to develop a survey that will be distributed to a larger sample of young
African American women. In this study, you will be asked to participate in a 60-minute
cognitive telephone interview to review provide feedback on an online survey. Interviews will
be audio-recorded and transcribed so that they are accurately reported.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation in this research study is voluntary. You do not have to participate in this
study. If you choose to participate, you may stop at any time without any penalty. You may also
choose not to answer particular questions that are asked in the study. Discontinuing your
participation or withdrawing from the study will not result in any loss or benefits to which you
are otherwise entitled. If you decide to join the study, you may withdraw at any time and for
any reason without penalty or loss of benefits.
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RISKS AND DISCOMFORTS
There are minimal risks associated with participation in this study. The questions asked in this
study should not cause any distress. However, in the case that you feel that you need mental
health services, Therapy for Black Girls is a great online resource to find local therapy
services provided by African American women. There are also mobile apps, such as
Betterhelp and Talkspace, that provide online therapy services.
PAYMENT FOR PARTICIPATION
As a display of our appreciation for your participation in this study, you will receive a $10 gift
card via mail after you complete the cognitive interview.
QUESTIONS
If you have any questions, concerns, or complaints about this study now or in the future, please
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu.
She is currently a doctoral candidate in the Department of Health Behavior and Policy at
Virginia Commonwealth University.
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Welcome and Introduction
Hello! Welcome to today’s cognitive interview session and thank you for taking the time to be here with
me. My name is Alesha Henderson and I will be conducting the interview today. I am a fourth-year,
social and behavior sciences, doctoral candidate in the Department of Health Behavior & Policy in the
School of Medicine at Virginia Commonwealth University.
Purpose: I’ve invited you here today to ask you to complete a survey so that I can get your perspectives
on a survey that will be distributed to other African American women between the ages of 18 and 30. The
survey broadly focuses on your knowledge of and perspectives towards hereditary breast cancer
mutations, potential population-wide testing for hereditary breast cancer mutations, and your health
communication preferences for messages about population-wide testing.
Process: I will ask you to respond verbally and on the online survey platform to questions from a
previously developed online survey. There are no right or wrong answers to the questions that I ask you.
After asking certain questions, I will ask you additional questions about your experience understanding
and responding to the question. Again, there are no right or wrong answers. Your responses will help to
create a better version of the survey to be distributed to a larger online sample.
This session is expected to last no more than 60 minutes and you will receive a $10 gift card for
compensation for your participation at the end of the survey. In-person participants will be handed their
compensation upon completion of the interview. Individuals who participate in the second round of
cognitive interviews will receive their compensation via mail. The session will be audio-recorded. The
recordings will not contain any names or personal information and will only be used for research
purposes.
In Case of Distress: The interview questions are not specific to your personal lives; however, you may
choose not to answer particular questions that are asked in the study. Your participation in this session is
completely voluntary. If at any time you feel uncomfortable or distressed, please don’t hesitate to stop me
at any time without any consequence. Also, please note that, for your safety, I will have to break
confidentiality if you mention that you have been harmed, are harming oneself, or have/will harm(ed)
others. As part of VCU’s policy and procedures, I will have to report this to the appropriate outlets.
At this time, we ask that you please take a moment to read the informed consent document.

Instructions for interviewer:
à Current probing questions begin at the description of direct to consumer testing.
(highlighted in red)
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à There are interview instructions for each question ( highlighted in grey )
à Probes have been created and listed under each of the questions of interest (highlighted
in yellow)
à Be sure to go through each question with each cognitive interview participants

Survey Begins Here:
Survey Introduction: I am currently conducting research on the perspectives of young African
American women between the ages of 18 and 30 on hereditary breast cancer mutations and the
potential for population-wide testing for hereditary breast cancer mutations for all women in the
United States among young women like yourselves. Questions will focus on your knowledge of
and perspectives towards hereditary breast cancer mutations, potential population-wide testing
for hereditary breast cancer mutations, and your health communication preferences for messages
about population-wide testing.
This survey should take approximately 20-25 minutes to complete.
If you have any questions about the survey, please email Alesha Henderson at
hendersonan2@vcu.edu.
Direct To Consumer Testing: Direct-to-consumer genetic tests are marketed directly to
customers via television, print advertisements, or the Internet, and the tests can be bought online
or in stores. Customers send the company a DNA sample and receive their results directly from a
secure website or in a written report. Direct-to-consumer genetic testing provides people access
to their genetic information without necessarily involving a healthcare provider or health
insurance company in the process (Retrieved February 4, 2020 from
https://ghr.nlm.nih.gov/primer/dtcgenetictesting/directtoconsumer).
Cognitive Interviewer questions start here!!!
Question Instructions for Interviewers:
Please Ask the following questions about the paragraph about direct to consumer testing above:
1. Paraphrase: Would you please repeat that to me in your own words?
2. Comprehension: What does the term “genetic test” mean to you?
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3. Comprehension: What does direct to consumer testing mean to you?
4. General probe: Was that easy or hard for you to read?

1. Do you know or have you heard of genetic tests that are provided directly to consumers via the
internet?
a. Yes
b. No

2. Have you ever done a genetic test which is provided directly to consumers via the internet?
a. Yes
b. No

Below are several statements describing why some people may do direct to consumer genetic
testing. Please indicate how much you agree each statement. For what reason/motivation
would you do direct to consumer genetic testing?

3. To know more about my health.
4. So that the doctor can monitor my
health.
5. To change my lifestyle (e.g.
dietary habits, exercise) in case the
genetic test shows that I have an
increased risk for a certain disease.
6. To inform my children about their
possible increased risk for a
disease.
7. Out of curiosity.
8. Out of scientific/ research interest
9. For fun.

Strongly
Disagree

Disagree

Agree

Strongly
Agree

2
2

Neither
Agree or
Disagree
3
3

1
1

4
4

5
5

1

2

3

4

5

1

2

3

4

5

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
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1. Paraphrase: Would you please repeat the main question in your own words?
2. General Probe: Can you take me through the steps of how you came to your answers for questions 12
through 18?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
12-18.

3. General probe: Were these questions easy or hard for you to answer?

Below are several statements describing why some people may not do direct to consumer
genetic testing. Please indicate how much you agree each statement. For what reason would
you not like to do direct to consumer genetic testing?

10. The results are unreliable.
11. The information will not be useful.
12. I wouldn’t like to know the risk I
have to develop a certain disease.
13. I worry about my personal data
and private life.

Strongly
Disagree

Disagree

Agree

Strongly
Agree

2
2
2

Neither
Agree or
Disagree
3
3
3

1
1
1

4
4
4

5
5
5

1

2

3

4

5

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
1. Paraphrase: Would you please repeat the main question in your own words?
2. General Probe: Can you take me through the steps of how you came to your answers for questions 19
through 22?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
19-22.
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3. General probe: Was that easy or hard for you to answer?

Question Instructions for Interviewers:
Probe about both direct to consumer scales:
4. General probe: Do you feel as if the description of direct to consumer testing provided sufficient
information to answer those two questions?

The next set of questions is to find out how much you may already know about genes for
cancer.

14. 50% (or half) of inherited genetic
information (about breast cancer risk) is
passed down from a person’s mother.
15. 25% of inherited genetic information (about
breast cancer risk) is passed down from a
person’s father.
16. There is more than one gene that can
increase the risk of breast cancer.
17. A woman who has a sister with a breast
cancer gene mutation has a 1 in 4 chance of
having a gene mutation herself.
18. One in ten women has a breast cancer gene
mutation.
19. Women who test positive for breast cancer
gene mutations are more likely to develop
breast cancer at a young age.

True

False

01

02

Don’t
know
3

01

02

3

01

02

3

01

02

3

01

02

3

01

02

3
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20. If a woman tests positive for a breast cancer
gene mutation, her male relatives’ risk for
developing prostate cancer are lowered
21. A woman may be at a greater risk for
developing ovarian cancer if she has several
close relatives with breast cancer.
22. A woman who has her healthy ovaries
removed will definitely not get ovarian
cancer.
23. A woman who has her breasts removed will
definitely not get breast cancer.
24. Screening for ovarian cancer often does not
detect a tumor until it’s more advanced.

01

02

3

01

02

3

01

02

3

01

02

3

01

02

03

Genetic Counseling: Genetic counseling is a communication process between a specially
trained health professional and a person concerned about the genetic risk of disease. The person's
family and personal medical history may be discussed, and counseling may lead to genetic
testing.
Question Instructions for Interviewers:
Ask the following questions about the paragraph about genetic counseling above:
1. General probe: Was that easy or hard for you to read?
2. Comprehension: In your own words, what is genetic counseling?
25. Have you ever heard about genetic counseling for hereditary breast cancer genes (e.g., Breast cancer
gene)?
a. Yes
b. No (skip pattern here)
26. If yes, how did you hear about genetic counseling for hereditary breast cancer genes (e.g., Breast
cancer gene)? Please check all that apply:

□ TV
□ Newspaper
□ Internet
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□ Friends
□ Family
□ Physician
□ Other health professional:
i.

Please specify __________________

27. Has your healthcare provider ever talked to you about genetic counseling for hereditary breast cancer
mutations?
a. Yes
b. No (Skip pattern to Question 29)

28. Did she/he give you a referral for genetic counseling?
a. Yes
b. No

Genetic Testing: Genetic testing for hereditary breast cancer looks for a mutation in your genes.
Genetic testing may or may not involve genetic counseling or meeting with a genetic counselor.
Question Instructions for Interviewers:
Ask the following questions about the paragraph about genetic testing above:
1. General probe: Was that easy or hard for you to read?
2. Comprehension: In your own words, what is genetic testing?

29. Have you ever heard about genetic testing for a hereditary breast cancer gene (e.g. BRCA)?
a. Yes
b. No (skip pattern to Question 31)

30. If yes, how did you hear about genetic testing for hereditary breast cancer mutations? Please check all
that apply:

□ TV
□ Newspaper
□ Internet
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□ Friends
□ Family
□ Physician
□ Other health professional:
i.

Please specify _________________

The next questions focus on your perspectives of hereditary breast cancer mutations.

31. If I were found to carry the gene,
it would help members of my
family like daughter(s) or sister(s)
decide whether to undergo genetic
testing.
32. Knowing that I carry the gene
would help me decide whether to
go for more frequent
mammograms.
33. Knowing whether or not I carry
the gene would increase my sense
of personal control.
34. Knowing that I do not carry the
gene would greatly improve my
quality of life.
35. My concerns about developing
breast cancer would be reduced if I
knew I did not carry the gene.
36. My concerns about developing
breast cancer would increase if I
knew that I carried the gene.
37. Knowing that I do not carry the
gene would not be helpful since I
could still develop breast cancer.
38. If I were found to carry the gene,
it would jeopardize my insurance

Strongly
Disagree

Disagree

Agree

Strongly
Agree

2

Neither
Agree or
Disagree
3

1

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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39.
40.
41.

42.

43.

coverage or lead to problems with
my employers.
If I were found to carry the gene,
it would cause others to view me
negatively.
If I were found to carry the gene,
it would lead to marital or family
problems.
Testing is not worthwhile because
it could yield inconclusive results
about whether I carry the gene for
breast cancer.
If I were found to carry the gene
for breast cancer, I would worry
about passing the gene to my
children.
If I were found to carry the gene, I
would worry that the results would
not stay confidential.

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
1. General Probe: Can you take me through the steps of how you came to that answer for each of the
perspectives towards hereditary breast cancer mutations listed in questions 40-52?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
in questions 40-52.

2. General probe: Were questions 40-52 easy or hard for you to answer?
3.

General probe: Do you feel as if the description of genetic counseling and testing provided sufficient
information to answer this question?

44. How likely do you think it is that you carry a hereditary breast cancer mutation?
a. Not at all likely
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b.
c.
d.
e.

Somewhat likely
Likely
Very Likely
Extremely likely

Question Instructions for Interviewers:
Please ask the following questions about the question above:
1. Paraphrase: Would you please repeat the question that I just asked you in your own words?
2. General Probe: Can you take me through the steps of how you came to that answer?
3. Specific Probe: Do you think it would be hard for other people to answer that question?

The next set of questions ask you to imagine the reaction you would have if you were to be
told you have a hereditary breast cancer mutation.

45. If I found out I carried a
gene mutation, it would
greatly disrupt my life.
46. Finding out I carried a
gene mutation would be
very difficult for me.
47. If I found out I carried a
gene mutation, I would
worry much more about
developing breast cancer.

Strongly
Disagree

Disagree

Neither agree
or disagree

Agree

Strongly
agree

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Question Instructions for Interviewers:
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Please ask the following questions related to the scale above:
1. General Probe: Can you take me through the steps of how you came to your answers for questions 5456?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
54-56.

2. General probe: Were those questions easy or hard for you to answer?
3. Specific Probe: Do you think it would be hard for other people to answer that question?

When getting health care, have you ever had the following things happen to you because of
your race or ethnicity?
Yes

No

Unsure

48. Been treated with less courtesy than other
people.
49. Been treated with less respect than other
people.
50. Received poorer service than others.

01

02

888

01

02

888

01

02

888

51. Had a doctor or nurse act as if he or she
thinks you are not smart?
52. Had a doctor or nurse act as if he or she is
afraid of you?
53. Had a doctor or nurse act as if he or she is
better than you?
54. Felt like a doctor or nurse was not listening
to what you were saying?

01

02

888

01

02

888

01

02

888

01

02

888

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
1. Paraphrase: Would you please repeat the main question in your own words?
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2. General Probe: Can you take me through the steps of how you came to your answers for questions 5763?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
57-63.

3. General probe: Was that easy or hard for you to answer?

Thinking about the relationship between various racial/ethnic groups and the American
medical system, please rate how strongly you agree or disagree with the following
statements. Please note, we are referring to your general feelings…

55. Doctors and health care
workers sometimes hide
information from patients
who belong to my
racial/ethnic group
56. Doctors have the best
interests of people of my
racial/ethnic group in mind
57. People of my racial/ethnic
group should not confide in
doctors and health care
workers because it will be
used against them
58. People of my racial/ethnic
group should be suspicious
(distrustful) of information
from doctors and health care
workers
59. People of my racial/ethnic
group cannot trust doctors
and health care workers
60. People of my racial/ethnic
group should be suspicious of
modern medicine

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Unsure

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888
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61. Doctors and health care
workers treat people of my
racial/ethnic group like
“guinea pigs”
62. People of my racial/ethnic
group receive the same
medical care from doctors
and health care workers as
people from other groups
63. Doctors and health care
workers do not take the
medical complaints of people
of my racial/ethnic group
seriously
64. People of my racial/ethnic
group are treated the same as
people from other groups
65. In most hospitals, people of
different racial/ethnic groups
receive the same kind of care
66. I have personally been
treated poorly or unfairly by
doctors or health care
workers because of my
racial/ethnic group.

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

1

2

3

4

5

888

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
1. Paraphrase: Would you please repeat the main statement in your own words?
2. General Probe: Can you take me through the steps of how you came to that answer for each of your
potential race-based experiences listed in questions 64-75?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
64-75.

3. General probe: Was that easy or hard for you to answer?
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The next questions ask about the ways you may or may not have relied on religion to deal
with life stressors.

67. Looked for a stronger
connection with God.
68. Sought God’s love
and care.
69. Sought help from
God in letting go of
my anger.
70. Tried to put my plans
into action together
with God.
71. Tried to see how God
was trying to
strengthen me in this
situation.
72. Asked forgiveness
for my sins.
73. Focused on religion
to stop worrying
about my problems.
74. Wondered whether
God had abandoned
me.
75. Felt punished by God
for my lack of
devotion.
76. Questioned God’s
love for me.
77. Wondered whether
my church had
abandoned me.

Not at all

Very
little

Somewhat

A great
deal

Not
Applicable

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

1

2

3

4

999

133

78. Decided the devil
made this happen to
me.
79. Questioned the power
of God.

1

2

3

4

999

1

2

3

4

999

Population-based testing for hereditary breast cancer mutations: There is a current proposal
about to offer genetic counseling and testing for hereditary breast cancer mutations to all women
in the United States starting at age 30. Please answer the next questions with this in mind.
Question Instructions for Interviewers:
Please ask the following questions about the paragraph above about population-based testing:
1. General probe: Was that easy or hard for you to read?
2. Comprehension: In your own words, what is population-based testing?

80. Now try to imagine that you are offered genetic testing and counseling for breast cancer susceptibility
through a population-based testing initiative at some point in the future, would you choose to have the
test
a.
b.
c.
d.
e.

No, Definitely not (1)
No, Probably not (2)
Unsure (3)
Yes, probably (4)
Yes, definitely (5)

Question Instructions for Interviewer:
Please ask the following about the question above:
1. Paraphrase: Would you please repeat the question in your own words?
2. General Probe: Can you take me through the steps of how you came to that answer?
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3. General probe: Was that easy or hard for you to answer?

The next questions ask you to imagine what members of your social circle would think of
you participating in population-based testing if it becomes available.

81. My friends would
approve of me
getting genetic
testing and
counseling through
population-based
testing.
82. My spouse would
approve of me
getting genetic
testing and
counseling through
population-based
testing.
83. My parents would
approve of me
getting genetic
testing and
counseling through
population-based
testing.
84. My siblings would
approve of me
getting genetic
testing and
counseling through
population-based
testing.
85. My other family
member would
approve of me
getting genetic

Strongly
Disagree

Disagree

Neither
Agree/Disagree

Agree

Strongly
Agree

Unsure

Not
applicable

01

02

03

04

05

888

999

01

02

03

04

05

888

999

01

02

03

04

05

888

999

01

02

03

04

05

888

999

01

02

03

04

05

888

999
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testing and
counseling through
population-based
testing.

Question Instructions for Interviewers:
Please ask the following questions related to the scale above:
1. Paraphrase: Would you please repeat the main statement in your own words?
2. General Probe: Can you take me through the steps of how you came to your answers for questions 9094 ?
a.

Allow the respondent to provide their rationale/ decision making process for scale responses
90-94.

3. General probe: Was that easy or hard for you to answer?

86. Would you be willing to pay out of pocket for genetic testing for breast cancer risk
through population-based testing?
□ Up to $50 (1)
□ Up to $100 (2)

□ Up to $200 (3) □ More than $500 (5)
□ Up to $500 (4)
□ I would not be willing to pay any money (6)

Question Instructions for Interviewers:
Please ask the following questions related to the question above.
1. Paraphrase: Would you please repeat the question in your own words?
2. General Probe: Can you take me through the steps of how you came to that answer?
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87. Imagine you had a strong need to get information about population-based testing for
hereditary breast cancer mutations. Where would you go first to get information? (Mark
only one)
a. Printed materials (for example, newspapers, magazines)
b. Health care provider (doctor, nurse, social worker)
c. Conversations with people you trust (friends, relatives, or co-workers)
d. Internet (Google or another search engine, WebMD or another medical website)
e. Social Media (Facebook, Instagram, Twitter)

88. Imagine you had a strong need to get information about population-based testing for
hereditary breast cancer mutations. Which of the following would you most trust as a
source of information about population-based testing for hereditary breast cancer
mutations? (Mark only one)
a. Printed materials (for example, newspapers, magazines)
b. Health care provider (doctor, nurse, social worker)
c. Conversations with people you trust (friends, relatives, or co-workers)
d. Internet (Google or another search engine, WebMD or another medical website)
e. Social Media (Facebook, Instagram, Twitter)

Thanks for completing the survey. The next questions ask you to provide demographic
information about yourself.

Demographic Survey
1. What is your age? _____
2. Do you have a family history of breast cancer?
a. Yes
b. No
3. Are you Hispanic or Latino?
a. Yes, Hispanic or Latino
b. Not, Hispanic or Latino
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4. Please tell me which category best describes your racial background?

a. Black or African American
b. White
c. Asian
d. American Indian/ Alaskan Native
f. Native Hawaiian or Other Pacific Islander (6)
g. More than One Race
h. Other: please specify __________________

5. What is your highest grade or level of schooling you have completed?
a. Less than high school
b. High School or general equivalency degree
c. Some college or technical school
d. Bachelor’s degree
e. Graduate Degree
6. Do you have health insurance?
a. Yes
b. No
c. Not sure
7. Do you have a regular physician or health care provider?
a. Yes
b. No
8. What is your income?
a. Less than $20,000
b. $20,000-$39,999
c. $40,000- $59,999
d. $60,000- $79,999
e. $80,000- $99,999
f. $100,000- $119,999
g. At least $120,000

9. What is your employment status?
a. Full-time
b. Part-time
c. Unemployed
d. Retired
e. Unable to work
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f. Homemaker
g. Student
10. What is your marital status?
a. Married
b. Living Together
c. Divorced
d. Widowed
e. Separated
f. Never Married
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Dissertation Survey 7.16
Start of Block: Block 1

Q30 What is your age?
________________________________________________________________
Skip To: End of Block If Condition: What is your age? Is Less Than 18. Skip To: End of Block.
Skip To: End of Block If Condition: What is your age? Is Greater Than 30. Skip To: End of Block.

Q33 Please tell me which category best describes your racial background?

o Black or African American (1)
o White (2)
o Asian (3)
o American Indian/ Alaskan Native (4)
o More than One Race (5)
o Other: please specify (6) ________________________________________________
Skip To: End of Block If Please tell me which category best describes your racial background? != Black or African
American

140

Q41 What is your gender?

o Male (1)
o Female (2)
o Other/Non-binary (3)
Skip To: End of Block If What is your gender? != Female

Q42 Do hereditary breast cancer mutations run in your family?

o Yes (1)
o No (2)
o I don't know (3)
End of Block: Block 1
Start of Block: Block 2
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Q43 RESEARCH PARTICIPANT INFORMATION SHEET
TITLE: Changing Landscapes: Perspectives of Young African American women of
Population-Wide Testing for Hereditary Breast Cancer Mutations
VCU IRB NO.: HM20015881
PRINCIPAL INVESTIGATOR: Alesha Henderson,
M.A.
Department of Health Behavior & Policy
Virginia Commonwealth University
Phone: 804-614-8304
Email:Hendersonan2@mymail.vcu.edu
Maghboeba Mosavel, PhD
Department of Health Behavior & Policy
Virginia Commonwealth University
Richmond, Virginia 23298-0149
Phone: (804) 628-2929
Fax: (804) 828-5440
PURPOSE OF THE STUDY
You are being invited to participate in this research study about population-wide testing
for hereditary breast cancer mutations and your health communication preferences. The results of
this study will be used to develop a survey that will be distributed to a larger sample of young
African American women. In this study, you will be asked to complete a 15-minute online
survey on the Qualtrics survey platform focusing on hereditary breast cancer mutations and
potential population wide testing for hereditary breast cancer mutations.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation in this research study is voluntary. You do not have to participate in this
study. If you choose to participate, you may stop at any time without any penalty. You may also
choose not to answer particular questions that are asked in the study. Discontinuing your
participation or withdrawing from the study will not result in any loss or benefits to which you
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are otherwise entitled. If you decide to join the study, you may withdraw at any time and for any
reason without penalty or loss of benefits.
RISKS AND DISCOMFORTS
There are minimal risks associated with participation in this study. The questions asked in this
study should not cause any distress. However, in the case that you feel that you need mental
health services, Therapy for Black Girls is a great online resource to find local therapy services
provided by African American women. There are also mobile apps, such as Betterhelp and
Talkspace, that provide online therapy services.
PAYMENT FOR PARTICIPATION
You will be compensated the amount you agree upon before you entered into the survey.
QUESTIONS
If you have any questions, concerns, or complaints about this study now or in the future, please
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu. She
is currently a doctoral candidate in the Department of Health Behavior and Policy at Virginia
Commonwealth University.
End of Block: Block 2
Start of Block: Default Question Block

Q1 Survey Introduction: I am currently conducting research on the perspectives of young
African American women between the ages of 18 and 30 on hereditary breast cancer mutations
and the potential for population-wide testing for hereditary breast cancer mutations for all
women in the United States among young women like yourselves. Questions will focus on your
knowledge of and perspectives towards hereditary breast cancer mutations, potential populationwide testing for hereditary breast cancer mutations, and your health communication preferences
for messages about population-wide testing. This survey should take approximately 15 minutes
to complete. If you have any questions about the survey, please email Alesha Henderson at
hendersonan2@vcu.edu.

Q2 Direct To Consumer Testing: Direct-to-consumer genetic tests are marketed directly to
customers via television, print advertisements, or the Internet, and the tests can be bought online
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or in stores. Customers send the company a DNA sample and receive their results directly from a
secure website or in a written report. Direct-to-consumer genetic testing provides people access
to their genetic information without necessarily involving a healthcare provider or health
insurance company in the process.

Q3 1. Do you know or have you heard of genetic tests that are provided directly to consumers
via the internet?

o Yes (1)
o No (2)
Q4 2. Have you ever done a genetic test which is provided directly to consumers via the
internet?

o Yes (1)
o No (2)
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Q5 Below are several statements describing why some people may do direct to consumer
genetic testing. Please indicate how much you agree with each statement. For what
reason/motivation would you do direct to consumer genetic testing?
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Strongly
disagree (1)

disagree (2)

Neither agree
nor disagree (3)

agree (4)

Strongly agree
(5)

3. To know
more about my
health. (1)

o

o

o

o

o

4. So that the
doctor can
monitor my
health. (2)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

5.To change my
lifestyle (e.g.
dietary habits,
exercise) in
case the genetic
test shows that I
have an
increased risk
for a certain
disease. (3)
6. To inform
my children
about their
possible
increased risk
for a disease.
(4)
7.Out of
curiosity. (5)
8. Out of
scientific/
research interest
(6)
9. For fun. (7)
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Q6 Below are several statements describing why some people may not do direct to consumer
genetic testing. Please indicate how much you agree with each statement. For what reason
would you not like to do direct to consumer genetic testing?
Strongly
disagree (1)

disagree (2)

Neither agree
nor disagree
(3)

agree (4)

Strongly agree
(5)

10. The results
are unreliable.
(1)

o

o

o

o

o

11. The
information
will not be
useful. (2)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

12. I wouldn’t
like to know
the risk I have
to develop a
certain disease.
(3)
13.
I
worry about
my personal
data and
private life. (4)
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Q7 The next set of questions is to find out how much you may already know about genes
for cancer.
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True (1)
14.
50% (or half) of
inherited genetic information
(about breast cancer risk) is
passed down from a person’s
mother. (1)

False (2)

o

o

15. 25% of inherited genetic
information (about breast cancer
risk) is passed down from a
person’s father. (2)

o

o

16. There is more than one gene
that can increase the risk of
breast cancer (3)

o

o

o

o

o

o

o

o

o

o

o

o

17. A woman who has a sister
with a breast cancer gene
mutation has a 1 in 4 chance of
having a gene mutation herself.
(4)
18.
One in ten women has a
breast cancer gene mutation (5)
19.
Women who test
positive for breast cancer gene
mutations are more likely to
develop breast cancer at a young
age. (6)
20.
If a woman tests
positive for a breast cancer gene
mutation, her male relatives’
risk for developing prostate
cancer are lowered (7)
21.
A woman may be at a
greater risk for developing
ovarian cancer if she has several
close relatives with breast
cancer (8)
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22.
A woman who has her
healthy ovaries removed will
definitely not get ovarian cancer
(9)

o

o

23.
A woman who has her
breasts removed will definitely
not get breast cancer (10)

o

o

24. Screening for ovarian cancer
often does not detect a tumor
until it’s more advanced. (11)

o

o

Q8 Genetic Counseling: Genetic counseling is a communication process between a specially
trained health professional and a person concerned about the genetic risk of disease. The person's
family and personal medical history may be discussed, and counseling may lead to genetic
testing.

Q9 25. Have you ever heard about genetic counseling for hereditary breast cancer genes
(e.g.,BRCA)?

o Yes (1)
o No (2)
Skip To: Q11 If 25. Have you ever heard about genetic counseling for hereditary breast cancer genes
(e.g.,BRCA... = No
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Q10 26. If yes, how did you hear about genetic counseling for hereditary breast cancer genes
(e.g., BRCA1 and BRCA2)? Please check all that apply:

▢
▢
▢
▢
▢
▢
▢

TV (1)

Newspaper (2)

Internet (3)

Friends (4)

Family (5)

Physician (6)

Other Health Profession: Please Specify (7)
________________________________________________

Q11 27. Has your healthcare provider ever talked to you about genetic counseling for hereditary
breast cancer mutations?

o Yes (1)
o No (2)
Skip To: Q13 If 27. Has your healthcare provider ever talked to you about genetic counseling for hereditary bre...
= No
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Q12 28. Did she/he give you a referral for genetic counseling?

o Yes (1)
o No (2)
Q13 Genetic Testing: Genetic testing for hereditary breast cancer looks for a mutation in your
genes.

Q14 29. Have you ever heard about genetic testing for hereditary breast cancer genes
(e.g. BRCA)?

o Yes (1)
o No (2)
Skip To: Q17 If 29. Have you ever heard about genetic testing for hereditary breast cancer genes (e.g. BRCA)? =
No
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Q15 30. If yes, how did you hear about genetic testing for hereditary breast cancer mutations.
Please check all that apply:

▢
▢
▢
▢
▢
▢
▢

TV (1)

Newspaper (2)

Internet (3)

Friends (4)

Family (5)

Physician (6)

Other Health profession: Please Specify (7)
________________________________________________
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Q17 The next questions focus on your perspectives of hereditary breast cancer mutations.
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Strongly
disagree (1)
31. If I were
found to carry
the gene, it
would help
members of
my family like
daughter(s) or
sister(s) decide
whether to
undergo
genetic testing.
(1)
32.
Knowi
ng that I carry
the gene would
help me decide
whether to go
for more
frequent
mammograms.
(2)
33. My
concerns about
developing
breast cancer
would be
reduced if I
knew I did not
carry the gene.
(5)

disagree (2)

Neither agree
nor disagree
(3)

agree (4)

Strongly agree
(5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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34. Knowing
whether or not
I carry the
gene would
increase my
sense of
personal
control. (3)
35. Knowing
that I do not
carry the gene
would greatly
improve my
quality of life.
(4)
36. My
concerns about
developing
breast cancer
would increase
if I knew that I
carried the
gene. (6)
37. If I were
found to carry
the gene, it
would
jeopardize my
insurance
coverage or
lead to
problems with
my employers.
(8)
38. If I were
found to carry
the gene, it
would cause
others to view
me negatively.
(9)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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39. If I were
found to carry
the gene, it
would lead to
marital or
family
problems. (10)
40. Knowing
that I do not
carry the gene
would not be
helpful since I
could still
develop breast
cancer. (7)
41. Testing is
not worthwhile
because it
could yield
inconclusive
results about
whether I carry
the gene for
breast cancer.
(11)
42. If I were
found to carry
the gene for
breast cancer, I
would worry
about passing
the gene to my
children. (12)
43. If I were
found to carry
the gene, I
would worry
that the results
would not stay
confidential.
(13)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q18

44. How likely do you think it is that you carry a hereditary breast cancer mutation?

o Not at all likely (1)
o Somewhat Likely (2)
o Likely (3)
o Very Likely (4)
o Extremely Likely (5)
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Q19 The next set of questions ask you to imagine the reaction you would have if you were to
be told you have a hereditary breast cancer mutation.
Strongly
disagree (1)
45.
If I
found out I
carried a gene
mutation, it
would greatly
disrupt my life.
(1)
46.
Findin
g out I carried
a gene
mutation
would be very
difficult for
me. (2)
47. If I found
out I carried a
gene mutation,
I would worry
much more
about
developing
breast cancer.
(3)

disagree (2)

Neither agree
nor disagree
(3)

agree (4)

Strongly agree
(5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q20 When getting health care, have you ever had the following things happen to you
because of your race or ethnicity?
Yes (1)

No (2)

o
o
o

o
o
o

o

o

o

o

53. Had a doctor or nurse act as
if he or she is better than you?
(6)

o

o

54. Felt like a doctor or nurse
was not listening to what you
were saying? (7)

o

o

48.
Been treated with less
courtesy than other people. (1)
49.
Been treated with less
respect than other people. (2)
50.
Received poorer
service than others. (3)
51. Had a doctor or nurse act as
if he or she thinks you are not
smart? (4)
52. Had a doctor or nurse act as
if he or she is afraid of you? (5)
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Q21 Thinking about various racial/ethnic groups and their interaction with the American
medical system, please rate how strongly you agree or disagree with the following
statements. Please note, we are referring to your general feelings…
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Strongly
disagree (1)
55.Doctors and
health care
workers
sometimes
hide
information
from patients
who belong to
my
racial/ethnic
group (1)
56.Doctors
have the best
interests of
people of my
racial/ethnic
group in mind
(2)
57.People of
my
racial/ethnic
group should
not confide in
doctors and
health care
workers
because it will
be used against
them (3)
58.People of
my
racial/ethnic
group should
be suspicious
(distrustful) of
information
from doctors
and health care
workers (4)

disagree (2)

Neutral (3)

Agree (4)

Strongly
Agree (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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59.People of
my
racial/ethnic
group cannot
trust doctors
and health care
workers (5)
People
of my
racial/ethnic
group should
be suspicious
of modern
medicine (6)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

60.

61.
Doctor
s and health
care workers
treat people of
my
racial/ethnic
group like
“guinea pigs”
(7)
62.

People
of my
racial/ethnic
group receive
the same
medical care
from doctors
and health care
workers as
people from
other groups
(8)
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63.Doctors and
health care
workers do not
take the
medical
complaints of
people of my
racial/ethnic
group
seriously (9)
People
of my
racial/ethnic
group are
treated the
same as people
from other
groups (10)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

64.

65.
In
most hospitals,
people of
different
racial/ethnic
groups receive
the same kind
of care (11)
66.
I have
personally
been treated
poorly or
unfairly by
doctors or
health care
workers
because of my
racial/ethnic
group. (12)
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Q22 The next questions ask about the ways you may or may not have relied on religion to
deal with life stressors.
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Not at all (1)

Very Little (2)

Somewhat (3)

A Great deal (4)

67.
Looked
for a stronger
connection with
God. (1)

o

o

o

o

68.
Sought
God’s love and
care. (2)

o

o

o

o

69.
Sought
help from God in
letting go of my
anger. (3)

o

o

o

o

70.
Tried to
put my plans into
action together
with God. (4)

o

o

o

o

o

o

o

o

72.
Asked
forgiveness for my
sins. (6)

o

o

o

o

73.
Focused
on religion to stop
worrying about
my problems. (7)

o

o

o

o

74.
Wondered
whether God had
abandoned me. (8)

o

o

o

o

75.
Felt
punished by God
for my lack of
devotion. (9)

o

o

o

o

71.
Tried to
see how God was
trying to
strengthen me in
this situation. (5)
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76.
Questione
d God’s love for
me. (10)

o

o

o

o

o

o

o

o

78.
Decided
the devil made this
happen to me. (12)

o

o

o

o

79. Questioned the
power of God.
(13)

o

o

o

o

77.

Wondered
whether my
church had
abandoned me.
(11)

Q23 Population-based testing for hereditary breast cancer mutations: There is a current
proposal to offer genetic counseling and testing for hereditary breast cancer mutations to all
women in the United States starting at age 30. Please answer the next questions with this in
mind.
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Q24 80. Now try to imagine that you are offered genetic testing and counseling for breast cancer
susceptibility through a population-based testing initiativeat some point in the future, would you
choose to have the test

o No, Definitely not (1)
o Not, Probably not (2)
o Unsure (3)
o Yes, probably (4)
o Yes, definitely (5)
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Q25 The next questions ask you to imagine what people close to you would think of you
participating in population-based testing if it becomes available.
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Strongly
Disagree (1)
81. My friends
would approve
of me getting
genetic testing
and counseling
through
populationbased testing.
(1)
82.
My
spouse would
approve of me
getting genetic
testing and
counseling
through
populationbased testing.
(2)
83.
My
parents would
approve of me
getting genetic
testing and
counseling
through
populationbased testing.
(3)
84.
My
siblings would
approve of me
getting genetic
testing and
counseling
through
populationbased testing.
(4)

Disagree (2)

Neither Agree/
Disagree (3)

Agree (4)

Strongly
Agree (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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85.
My
other family
member would
approve of me
getting genetic
testing and
counseling
through
populationbased testing.
(5)

o

o

o

o

o

Q26 86. Would you be willing to pay out of pocket for genetic testing for breast cancer risk
through population-wide testing?

o Up to $50 (1)
o Up to $100 (2)
o Up to $200 (3)
o Up to $500 (4)
o More than $500 (5)
o I would not be willing to pay any money (6)
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Q27 87. Imagine you had a strong need to get information about population-based testing for
hereditary breast cancer mutations. Where would you go first to get information? (Mark only
one)

o Printed materials (for example, newspapers, magazines) (1)
o Health care provider (doctor, nurse, social worker) (2)
o Conversations with people you trust (friends, relatives, or co-workers) (3)
o Internet (Google or another search engine, WebMD or another medical website) (4)
o Social Media (Facebook, Instagram, Twitter) (5)
Q28 88. Imagine you had a strong need to get information about population-based testing for
hereditary breast cancer mutations. Which of the following would you most trust as a source of
information about population-based testing for hereditary breast cancer mutations? (Mark only
one)

o Printed materials (for example, newspapers, magazines) (1)
o Health care provider (doctor, nurse, social worker) (2)
o Conversations with people you trust (friends, relatives, or co-workers) (3)
o Internet (Google or another search engine, WebMD or another medical website) (4)
o Social Media (Facebook, Instagram, Twitter) (5)
Q29 Thanks for completing the survey. The next questions ask you to provide demographic
information about yourself.

173

Q31 1. Do you have a family history of breast cancer?

o Yes (1)
o No (2)
Q32 2. Are you Hispanic or Latino?

o Yes, Hispanic or Latino (1)
o Not, Hispanic or Latino (2)
Q34 3. What is your highest grade or level of schooling you have completed?

o Less than high school (1)
o High school graduate (2)
o Some college or technical degree (3)
o Bachelor's degree (4)
o Graduate degree (5)
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Q35 4.

Do you have health insurance?

o Yes (1)
o No (2)
o Not sure (3)
Q36 5. Do you have a regular physician or health care provider?

o Yes (1)
o No (2)
Q37 6. What is your income?

o Less than $20,000 (1)
o $20,000-$39,999 (2)
o $40,000- $59,999 (3)
o $60,000- $79,999 (4)
o $80,000- $99,999 (5)
o $100,000- $119,999 (6)
o At least $120,000 (7)
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Q38 7. What is your employment status?

o Full-time (1)
o Part-time (2)
o Unemployed (3)
o Retired (4)
o Unable to work (5)
o Homemaker (6)
o Student (7)
Q39 8. What is your marital status?

o Married (1)
o Living Together (2)
o Divorced (3)
o Widowed (4)
o Separated (5)
o Never Married (6)
End of Block: Default Question Block
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